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ABSTRACT
Life may have begun in an RNA world, which is supported by the increasingly vital role
that RNA has been shown to perform in biological systems. To understand how the genome
encodes life, one must look to the transcriptome, the set of all RNA molecules in a cell.
The transcriptome illustrates which RNA transcripts are expressed at what times and this
orchestrated network of gene expression is responsible for multicellular development. In
humans, most genes are noncoding RNAs, meaning that they do not encode proteins. The
largest class of noncoding genes are long noncoding RNAs (lncRNAs), RNA transcripts
greater in length than 200 nucleotides which lack protein-coding capacity. Some lncRNAs
have been shown to be key regulators; however, most lncRNAs are uncharacterized.
Therefore, we developed genomic data mining methodologies for lncRNA functional
annotation.
Many lncRNAs are brain-specific and their dysregulation is suspected to be
involved in neurodevelopmental disorders. Two prevalent brain disorders are intellectual
disability (ID) and autism spectrum disorder (ASD), which are genetically heterogeneous
with unidentified genetic risk factors. In this study, we created brain developmental gene
coexpression networks, for ID and ASD, to identify lncRNAs associated with known
disease genes. We found lncRNAs highly co-expressed with ID genes which harbored IDassociated copy number variants (CNVs). To find ASD-associated lncRNAs we identified
lncRNAs differentially expressed in the ASD brain and then refined these candidates by
filtering for associations with ASD risk genes in a human brain developmental
coexpression network. These candidate-ASD associated lncRNAs were associated with the
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synaptic transmission and immune response pathways, in addition to residing within ASDassociated CNVs at a high frequency.
The mechanism by which lncRNAs function is partly determined by functional
motifs in the RNA transcript sequence. To identify lncRNA motifs, we developed a genetic
algorithm capable of finding long motifs and found a motif associated with lncRNA nuclear
localization. LncRNA functions are compartmentalized within the cell; therefore,
knowledge of lncRNA subcellular localization provides insight into their biological
function. We developed a deep learning model that predicts lncRNA subcellular
localization from lncRNA transcript sequences. This model obtained high prediction
accuracy on lncRNAs with known localizations suggesting that sequence motifs are
involved in subcellular localization. In summary, we developed genomic data mining
methods for the functional characterization of lncRNAs based on their expression patterns
and transcript sequences.
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CHAPTER I - LITERATURE REVIEW OF THE FUNCTIONAL ANNOTATION
OF LONG NONCODING RNAS THROUGH GENOMIC DATA MINING

1.1 Introduction
The human genome project was a monumental journey to sequence the entire set of human
chromosomes which many scientists believed would unlock the secrets of our genome. However,
after the completion of the human genome it was discovered that in terms of number of genes,
which encoded proteins, humans were somewhere between chickens and grapes (Pertea and
Salzberg, 2010). This was a surprise to the scientific community, which preceding the completion
of the human genome had estimated around 100,000 human genes only to discover about 22,000
(Pertea and Salzberg, 2010). This relatively small number of genes corresponds to only a few
percent of the total human genome, while the rest of the noncoding genome does not encode
proteins. This noncoding DNA was referred to as “junk DNA” because of its lack of protein-coding
capacity and the presence of noncoding RNAs, transposons, pseudogenes and repetitive regions.
The advent of microarray hybridization technologies allowed the genome-wide detection
of noncoding RNAs, which showed the pervasiveness of transcription in the genome. From these
genome-wide analyses it is now known that the majority of the genome is actively transcribed
(Hangauer, et al., 2013). Why would natural selection favor the transcription, which costs energy,
of “junk DNA” with no biological purpose? This question rests on the assumption that junk DNA
has no function, which is now known to be invalid. The term “junk DNA” is obsolete after genomic
analyses discovered that 80% of the human genome possess biochemical functions (Bernstein, et
al., 2012). Genomics research has not only shed light on the dark matter of the genome but also
championed for a redefinition of the term gene, due to the vast amount of evidence for functional
noncoding RNAs. Genes are no longer always required to encode proteins, thus creating two major

1

classes of genes, those which encode proteins are protein-coding while those that do not are
noncoding RNAs (ncRNAs). This redefinition is of tremendous importance because both
noncoding and protein-coding genes are functionally intertwined within the gene network of the
genome.
High-throughput RNA-sequencing has largely supplanted microarrays due to the ability to
discover novel RNA transcripts, which has resulted in the discovery of tens of thousands of long
noncoding RNAs (lncRNAs). LncRNAs are RNA transcripts greater than 200 nucleotides in length,
which do not encode proteins. The nucleotide length threshold of 200 nucleotides is largely
arbitrary but does serve a key purpose to separate these transcripts from the well-known small
noncoding RNAs, such as transfer RNA (tRNA), micro RNA (miRNA) and small nucleolar RNA
(snoRNA). A meta-analysis of 7,256 human RNA-sequencing libraries identified 58,648 lncRNA
genes, suggesting that 68% of the human transcriptome could be lncRNAs (Iyer, et al., 2015). In
total, Iyer et al, identified about 99,000 human genes, which is quite close to the estimate of 100,000
prior to the human genome project, however only approximately 22,000 are protein-coding genes
(Iyer, et al., 2015). While this estimate of lncRNAs may be high due to the inclusion of tumor
samples, the current GENCODE annotation set (V27), a gold-standard for lncRNA annotation,
contains 15,778 lncRNA genes (Harrow, et al., 2006). Therefore, it is evident that lncRNAs are
abundant within the human genome with active biological functions.
LncRNAs represent the largest class of noncoding genes with several sub-classes based on
their genomic position relative to protein-coding genes. In order of decreasing prevalence, the
major lncRNA classifications are long intergenic noncoding RNAs (lincRNAs), antisense lncRNAs
(AS-lncRNAs), sense lncRNAs and bidirectional lncRNAs (Derrien, et al., 2012). LncRNAs are
most commonly transcribed by RNA polymerase II and generally post-transcriptionally modified
just like mRNAs, including 5’ capping, polyadenylation and splicing (Quinn and Chang, 2015).
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Indeed, the biogenesis of lncRNAs is suggested to be very similar to mRNAs in most cases.
Recently, a key difference between the biogenesis of lncRNAs and mRNAs was discovered,
knockouts of the ribonuclease Dicer, responsible for generating miRNAs, resulted in the decreased
expression levels of hundreds of lncRNAs, yet not mRNAs (Zheng et al., 2014). This discovery
suggests lncRNA biogenesis may function in a regulatory network with miRNAs. Another
intriguing difference between mRNAs and lncRNAs is that some lncRNA transcripts possess
higher-order structures, like 3′ secondary cloverleaf structures similar to tRNAs. These 3′
secondary structures are cleaved by ribonuclease P to form the mature lncRNA with a 3′ triple helix
structure which is predicted to increase transcript stability and facilitate nuclear retention (Quinn
and Chang, 2015). While there are many classifications of lncRNAs they generally share common
features, including that they are predominantly spliced, expressed at low levels, are tissue-specific
and their exonic regions have low levels of interspecies sequence conservation (Derrien, et al.,
2012). Furthermore, lncRNA promoters are conserved at a similar level relative to protein-coding
genes which suggests that they are positively selected and therefore functionally important
(Derrien, et al., 2012).

1.2 Biological function of lncRNAs
The functions of lncRNAs are generally within four major mechanistic themes,
which are to act as a signal, decoy, guide or scaffold (Wu, et al., 2013). These different
mechanisms can act to regulate other genes at the transcriptional, post-transcriptional,
translational, or epigenetic levels. LncRNAs with signaling functions act as a molecular
marker to indicate specific biological conditions which then induces a response such as
histone modification. An example is the lncRNA Xist which signals X-chromosomal
inactivation in females for dosage compensation, by coating the chromosome in Xist
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transcripts which signals successive epigenetic modifications such as DNA methylation,
histone methylation and histone ubiquitination (Morris, 2016). Decoy lncRNAs function
through sequence-based competitive binding of molecules, such as miRNAs which thereby
reduces miRNA efficacy. This is commonly observed with lncRNAs acting as miRNA
sponges, by binding miRNAs and therefore preventing the translational repression of the
miRNAs targets (Geisler and Coller, 2013). Guide lncRNAs bind proteins, such as
transcription factors, thereby guiding these complexes to specific genomic loci (Werner
and Ruthenburg, 2015). Many lncRNAs function as guides by tethering to chromatin and
facilitating the binding of protein complexes such as PRC2 and RNA polymerase II
(Werner and Ruthenburg, 2015). The last major lncRNA functional theme, that is currently
known, is to act as a scaffold, which mediates the physical interaction between other
proteins and ncRNAs, forming ribonucleoprotein complexes. The lncRNA HOTAIR
directly facilitates the binding of E3 ubiquitin ligases with multiple substrates for
ubiquitination such as Ataxin-1 and Snurportin-1, thereby acting as scaffold for protein
ubiquitination (Yoon, et al., 2013). It is important to note that one lncRNA is not confined
to a single functional mechanism and can exhibit multiple functions simultaneously.
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Figure 1.1 Functional themes of lncRNAs. LncRNAs are shown in purple performing the
four main functional themes of lncRNAs. Signaling lncRNAs act in response to a stimulus
to induce gene regulation, such as repression, in a spatiotemporal manner. Decoy lncRNAs
act as competitive inhibitors, such as miRNA sponges thereby preventing the degradation
of the targeted mRNA. Guide lncRNAs bind complexes such as chromatin modifying
enzymes and facilitate the targeting to specific genomic loci either in cis or trans. Scaffold
lncRNAs act as molecular glue to facilitate the interaction of multiple proteins into a
ribonucleoprotein complex. Modified from (Wang and Chang, 2011)

1.3 Subcellular localization of lncRNAs
LncRNAs are not all in the nucleus; some localize to distinct subcellular localizations,
such as the chomatin, cytosol, polysomes and exosomes (Kogure, et al., 2013; Heesch, et
al., 2014; Chen, 2016). Like proteins, lncRNA functionality is dependent on proper
subcellular localization. While many studies suggest that lncRNAs are predominantly
enriched in the nucleus, there is countervailing evidence of lncRNA cytoplasmic
enrichment (Derrien, et al., 2012; Ulitsky and Bartel, 2013; Heesch, et al., 2014; Werner
and Ruthenburg, 2015). However, the factors that govern lncRNA subcellular localization
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are mostly unknown. Recently, a nuclear retention motif was identified in the lncRNA
BORG through a mutational screen (B. Zhang, et al., 2014). This motif contained a
pentamer sequence with two upstream restriction sites and mutations of the motif resulted
in loss of nuclear retention (B. Zhang, et al., 2014). Furthermore, the number of copies of
this motif present in lncRNAs is correlated with the nuclear to cytoplasmic transcript ratio.
The subcellular localization of lncRNAs can reveal insights into their functionality due to
the fact that certain lncRNA functionalities are specific to certain cellular locations. Gene
regulation by lncRNAs, at the transcriptional, post-transcriptional or epigenetic levels is
performed within the nucleus (Sun, et al., 2017). However, translational regulation, binding
of miRNAs, subcellular trafficking and processing to produce small ncRNAs are all
lncRNA functions exclusive to the cytoplasm (Rashid, et al., 2016). Therefore, predicting
the subcellular localization of lncRNAs can provide useful information regarding its
biological function.
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Figure 1.2 LncRNA cellular functions. (1) LncRNAs can bind chromatin modifying
enzymes and facilitate histone modifications such as the trimethlyation of histone 3 at
lysine 27 (me3K27) inducing gene silencing. (2) LncRNAs are able to form an RNA-DNA
triplex which blocks accessibility to gene promoter regions. (3) LncRNAs facilitate the
nuclear organization of subcellular structures like nuclear paraspeckles. (4) Alternative
splicing can be regulated by lncRNAs ability to bind intronic segments of pre-mRNA. (5)
LncRNAs can bind mRNA and ribosomes to regulate translation. (6) LncRNAs are capable
of sequestering miRNAs as a miRNA sponge thereby preventing the degradation of the
targeted mRNA. (7) LncRNAs can be processed by enzymes such as Dicer to form small
ncRNAs like endogenous small interfering RNAs (siRNAs) leading to RNA interference.
(8) LncRNAs can function in the subcellular localization of proteins to complexes such as
the proteasome. Figure Modified from (Rashid, et al., 2016)
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1.4 LncRNAs in human disease
LncRNAs have been implicated in many human diseases. This is not surprising because
they are versatile regulators of gene expression with known roles in tissue development.
Mutations in lncRNAs can alter their functional efficacy thereby causing aberrant
downstream consequences. Interestingly, more than 90% of disease-associated SNPs are
found within noncoding regions of the human genome (Maurano, et al., 2012; RicañoPonce and Wijmenga, 2013). Disease-associated single nucleotide variants (SNPs) can
alter the expression levels of lncRNAs (Kumar, et al., 2013). In addition, copy-number
variants, another major source of disease, have also been shown to change lncRNA
expression levels, which has been associated with cancer (Xu, et al., 2017). Aberrant
lncRNA expression can dysregulate biological pathways which can be associated with
disease.
A significant fraction of lncRNAs are specifically expressed in neuronal tissues,
therefore we would expect lncRNAs to also be involved in brain disorders (Derrien, et al.,
2012). In mammals, lncRNAs have direct roles in neural differentiation and synaptic
plasticity (Wu, et al., 2013; Clark and Blackshaw, 2014). Therefore, it is no surprise that
lncRNAs have been implicated in neurodegenerative, psychiatric and neurodevelopmental
disorders. For example, the lncRNA BACE1-AS increases the stability of the antisense
BACE1 mRNA, thereby reinforcing a positive feedback loop increasing beta amyloid
levels (Faghihi, et al., 2008). Beta-amyloid peptides can aggregate into extracellular
amyloid plaques which are toxic to neurons and can be seen in Alzheimer brains. Two of
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the most predominant neurological disorders, intellectual disability (ID) and autism
spectrum disorder (ASD), are genetically heterogeneous.
ID and ASD affect up to 3% and 1%, respectively, of the human population causing
social, economic and health problems worldwide (Srivastava and Schwartz, 2014). ID is
characterized by diminished intellectual capacity and adaptive reasoning, while ASD is
recognized by impaired social communications and restrictive or repetitive behavior. Both
disorders originate in early childhood and have a large genetic component, yet are
genetically heterogeneous with hundreds of implicated risk genes. A large fraction of genes
involved in these disorders are associated with the synaptic transmission pathway,
supporting the notion that this crucial biological pathway is disrupted or dysregulated in
ID and ASD (Verpelli, et al., 2013; De Rubeis, et al., 2014) . Moreover, up to 70% of
people with ASD also have some form of ID, while 10% of people with ID have some form
of ASD (Srivastava and Schwartz, 2014). In most cases of ID or ASD, the exact genetic
casual factors of these disorders is unable to be determined, despite being highly genetic
disorders as determined by heritability estimates (O’Roak, et al., 2012; Kiser, et al., 2015).
However, until recently, only protein-coding genes were studied for involvement in these
disorders. Therefore, due to large fraction of cases without an identifiable genetic diagnosis
it is probable that the majority of genetic risk factors of ID and ASD reside outside the
exome, such as in lncRNAs. Recently, studies have shown involvement of lncRNAs in
both disorders (Vondervoort, et al., 2013)
LncRNAs are implicated in many intellectual disability syndromes, such as CoffinSiris syndrome, Prader-Willi Syndrome, Fragile X-syndrome and Rett syndrome
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(Vondervoort, et al., 2013). An ultra-conserved lncRNA named Evf2 was shown to bind
the protein BRG1, part of the SWI/SNF nucleosome remodeling complex, and localize to
enhancers causing enhancer repression (Cajigas, et al., 2015). Interestingly, mutations
causing Coffin-Siris syndrome, a syndromic intellectual disability, were found to reside in
the RNA-binding domain of BRG1 thereby implicating the lack of Evf2-induced
transcriptional repression in this disorder (Cajigas, et al., 2015). In ASD, hundreds of
lncRNAs were found to be differentially expressed in the prefrontal cortex of ASD patients
relative to controls (Ziats and Rennert, 2013). Furthermore, the observed differences in
lncRNA expression between the prefrontal cortex and cerebellum of ASD patients were
significantly lower than between the same brain regions in controls (Ziats and Rennert,
2013). In addition, several specific lncRNAs, such as ST70T1 and PTCHD1AS1 have been
associated with ASD through population sequencing studies (Vondervoort, et al., 2013).
In a genomic differential expression analysis of ASD leukocytes over 3,000 lncRNAs were
found to be differentially expressed, including thirteen lncRNAs associated with synaptic
functions (Wang, et al., 2015). These results suggest that lncRNAs are involved in the
development of both ID and ASD, which could help identify novel genetic risk factors.

1.5 Genomic data mining
Investigation into biological functions of lncRNAs experimentally, such as gene
knockouts, is a highly time-consuming and laborious process which is not easily amenable
to parallelization. However, genomic data mining offers a solution to these obstacles.
Genomic data mining is the process of utilizing biological datasets to extract hidden
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knowledge regarding a specific biological question. Knowledge is gained through the use
of data mining algorithms which identify patterns and relationships within the data.
Genomic data mining typically consists of three major steps, which are dataset acquisition,
data integration and application of data mining algorithms.
Dataset acquisition involves the querying of databases, which are generally
publicly available, for biological data which are relevant to the hypothesis at hand. Data
integration is the aggregation of diverse or heterogeneous datasets to common formats so
that statistical learning can identify generalizable knowledge which is not confounded by
variables of individual datasets. Lastly, data mining algorithms, such as coexpression
network analysis or deep learning, can be applied to the data for knowledge discovery to
help answer a biological question. While still a relatively new discipline, genomic data
mining is of monumental importance and will continue to grow in demand proportionally
to the vast amount of data being generated. The sequence read archive (SRA), a
bioinformatics database for sequencing data, was founded in 2007 and by 2017 already
contained over 1000 terabytes of sequencing data. This is only one database, but highlights
the need for genomic data mining methodologies to be able to extract knowledge from this
explosion of biological data.
A subfield of data mining is machine learning. Machine learning is the creation of
models which learn from data, on their own without explicit instructions, to generate
predictions for new data instances. Machine learning algorithms use a dataset as input
which is composed of data instances, generally referred to as samples in biology, and
features that describe these data instances. Therefore the more informative your features
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are regarding the problem at hand, the better your prediction results will be. Machine
learning is further subdivided into supervised and unsupervised learning. Supervised
learning is the process of learning from labeled data in which the response variable, the
feature that needs to be predicted, is already known. This allows the learning of
generalizable knowledge which can be used to predict the response variable for new data
instances with unknown labels. Unsupervised learning is the act of learning from unlabeled
data to identify hidden structure within the data for the clustering of data instances into
representative groups. Therefore, supervised learning requires a training set with a labelled
response variable, a categorical or numeric value, for which to predict, while unsupervised
learning does not require labelled data. Both types of machine learning are widely used for
the functional annotation of genes.
Supervised machine learning algorithms are used more frequently in genomics due to
their ability to predict variables of interest. The ability to make biologically relevant
predictions from genomic data has garnered intense interest due to the capability of
machine learning algorithms to learn novel complex patterns and structure within complex
data. Due to the growing size and complexity of genomic data, machine learning algorithms
are needed to discover knowledge in a timely and efficient manner. Two of the most
popular machine learning algorithms are the support vector machine (SVM) and random
forest (RF). Both of these algorithms are easy to implement due to a small number of
parameters, but can achieve high accuracy for both linear and non-linear problem
specifications. SVMs and RFs have been used for a diverse array of biological problems
from the classification of lncRNAs to the prediction of lncRNA-protein interactions and
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ASD-associated lncRNAs (Muppirala, et al., 2011; Cogill and Wang, 2016; Pian, et al.,
2016). While SVMs or RFs have achieved superior prediction accuracy in most problems,
recently a new set of advanced machine learning algorithms, known as deep learning
algorithms have attained first-rate prediction accuracy in complex problems (Ching, et al.,
2017).
Deep learning is a term for a group of algorithms utilizing deep artificial neural
networks, which mimic how biological brains function through the aggregation of artificial
neurons. Artificial neurons are connected to the input features and through randomized
transformations, each neuron learns a different representation of the input data. The
neurons that are connected to the features, are then connected to another layer of neurons,
which learn from the first layer’s output. Therefore, layers of neurons learn from the
previous layer and pass on their information to the next layer, meaning each layer learns
more complex features of the input data instances. The number of neuronal layers are what
give a deep learning model its depth, with each layer transforming its inputs to discover
new more advanced features. The discovery of more complex representative features is the
main advantage of deep learning techniques over other machine learning algorithms which
are restricted to the input features provided. Issues with deep learning include that it
requires big datasets to learn generalizable knowledge due to the copious number of
parameters that need to be tuned. However, in the age of big data this is becoming less of
a concern which is why deep learning will become the next frontier of machine learning in
genomics.
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In addition to machine learning, evolutionary algorithms, such as the genetic algorithm,
are widely used for genomic data mining (Ujjwal, et al., 2011). Genetic algorithms can
solve difficult optimization problems due to their ability to stochastically evolve solutions
over time, like natural selection. This works by first generating many possible candidate
solutions, generally at random, which then evolve towards superior solutions. Genetic
algorithms are an iterative process which consists of steps which are continuously repeated
over a course of generations, until the best solution can no longer be improved upon. Every
solution consists of smaller indivisible pieces, like chromosomes, which in total make up
all the properties of the solution. For example, to discover regulatory motifs in the flanking
regions of genes, a genetic algorithm was created which used 7-letter substrings of DNA
as candidate solutions (Liu, et al., 2004). These candidate motifs were then mutated and
mated with each other through crossover for hundreds of generations to find enriched DNA
binding motifs. Two major types of genomic data mining for lncRNA functional annotation
are discussed below.

1.6 Expression-based methods for lncRNA functional annotation
A well-known property of lncRNAs is their tissue and developmental specificity,
and thus the expression profile of lncRNAs can be used to help identify its biological
function. These methods are especially useful for lncRNAs because they do not encode
proteins, therefore the RNA is the functional unit and lncRNA transcript abundances are
proportional to their functionality. In contrast, the correlation between a protein and their
cognate mRNA abundance has been suggested to be rather poor (Maier, et al., 2009). The
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biological functions of lncRNAs can be investigated by examining the differences in
expression levels between different groups of samples, such as disease vs control tissues
or fetal brains vs adult brains. The two most prominent expression-based approaches are
differential gene expression analysis and coexpression network analysis.
Differential gene expression analysis identifies genes which have statistically
significant differences in expression levels between two conditions and is commonly used
to find genes associated with a disease, tissue-type or experimental treatment. Differential
gene expression is a useful method to screen for lncRNAs that may be involved in a
condition of interest. However, insights regarding their biological function are limited,
although this screening allows for much more efficient further experimentation, such as
gene knockouts, to establish the lncRNA’s biological function. For example, differential
expression analysis after chemical activation of p53, a tumor suppressor gene, on three
different cell lines showed strong up-regulation of an unknown lncRNA, which was
subsequently named p53-induced noncoding RNA (PINCR) (Chaudhary, et al., 2017). A
gene knockout was performed to functionally characterize PINCR resulting in the
discovery that PINCR regulates targets of p53 that manage G1 arrest following DNA
damage (Chaudhary, et al., 2017). Differential expression can also reveal lncRNAs which
are tissue-specific and may have developmental functions such as the lncRNA, linc-PINT.
This lncRNA was found to be up-regulated in radial glial cells of the developing human
brain, gene knockouts subsequently suggested this lncRNA functions in cell proliferation
(Liu, et al., 2016). While gene knockouts are a valuable experimental tool for lncRNA
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functional annotation they are costly and laborious, unlike gene coexpression network
analysis.
Gene coexpression network analysis is an unsupervised clustering method which
enables the inference of gene’s biological function based on the strength of connections to
genes of known function. This method clusters genes by their expression profiles into
groups of genes, known as gene modules. These gene modules are then functionally
annotated through gene set enrichment analysis which uses a statistical test to check if the
overall functional enrichment is different than what would be expected by random chance.
Gene coexpression network analysis leverages the biological properties of known genes to
gain insight on the uncharacterized genes through a guilt-by-association heuristic. One of
the first applications of this technique for the annotation of lncRNA functions was done
using microarrays in mice resulting in the predicted annotation of 340 lncRNAs based on
coexpression, network characteristics and genomic adjacency (Liao, et al., 2011). These
mouse lncRNAs were associated with processes mainly involved in tissue development,
cellular transport and metabolic functions (Liao, et al., 2011). Coexpression networks were
also used to infer the biological functions of lncRNAs conserved in primates, finding
functional associations for fundamental mammalian processes including spermatogenesis,
synaptic transmission and placental development (Necsulea, et al., 2014). One concern for
expression-based methods for lncRNA functional annotation is that gene expression is
dependent on the tissue type, therefore without the relevant dataset the analysis is not
possible. However, sequence-based methods for functional annotation are applicable, in
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this case, because the lncRNA transcript is the same regardless of what cell type it is
expressed in.

Figure 1.3 Overview of coexpression network analysis. Genes are clustered based on their
correlation of gene expression with other genes resulting in gene modules, shown in
different colors. Within each gene module, nodes represent genes while edges represent
correlations. The length of each edge is inversely proportional to its correlation so the
shorter the edge the higher the coexpression. Genes are then annotated based on the
functional enrichment of the known genes in the module.

1.7 Sequence-based methods for lncRNA functional annotation
LncRNA biological functionality resides in the primary sequence, such as motifs, or
from the 3D structure. However, the prediction of lncRNA structure is a research area still
in its infancy, mainly due to the paucity of experimentally validated lncRNA structures.
Since sequence ultimately dictates structure, the capacity of lncRNAs to bind RNA, DNA
and proteins, therefore, is present within the lncRNA primary sequence. While lncRNAs
are generally conserved at low levels, functional motifs have been identified in lncRNA
sequences, such as miRNA and DNA binding sites. In addition, sequence motifs have been
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found which are associated with specific lncRNA higher-order structures such as the
AUGC tetraloop motif (Li, et al., 2016). Moreover, lncRNA sequence motifs have been
found to be directly involved in their post-transcriptional modifications as well as
subcellular localization (Mondal et al., 2015; Zhang et al., 2014). The motifs present in the
lncRNA transcript therefore provide insight into its mechanism of action.
LncRNA transcript sequences can be utilized as inputs into genomic data mining
algorithms to identify motifs or make functional predictions. Almost all machine learning
algorithms require a fixed number of input features which creates a challenge due to
lncRNA nucleotide sequences of variable length. A common way around this issue is to
transform the sequences into k-mers of all possible substrings of a fixed length k. The
number of k-mers grows exponentially with the selection of k, therefore most sequencebased methods using nucleotides as inputs use 4-mers, which equals 256 unique DNA 4mers. Larger k-mers are more informative but as the number of features increases, so
should the number of data instances in your training data, to prevent overfitting. K-mers
can be highly informative features because they can contain known functional motifs
without having to know the motif beforehand. However, k-mers contain only local
sequence information and cannot include long-range sequence interactions, unlike
structural features.
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Figure 1.4 Deriving sequence-based features using k-mers. K-mers are all possible
substrings of length K in a sequence, which are counted to form a K-mer matrix. This
method allows the derivation of a fixed number of features from sequences of variable
lengths.

LncRNA sequences can also be used as inputs into structural prediction algorithms that
predict secondary structure conformations, which can then be used to derive structural
associated features (Lorenz, et al., 2011). These structurally derived features commonly
include vectors of hydrogen bonding, minimum free energy secondary structures, RNA
loops and the number of possible structural conformations (Lorenz, et al., 2011).
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LongTarget, a prediction model for lncRNA DNA-binding motifs, was developed based
on traditional and hoogstein base-paring features which can predict DNA binding sites in
lncRNA sequences that form RNA-DNA triplexes (He, et al., 2018). RNA-RNA
interactions have also been predicted using RNA sequences to infer the minimum free
energy secondary structure of the interacting RNAs using a genetic algorithm (Montaseri,
et al., 2014). While predicting structural features using lncRNA sequences can be
informative, lncRNA structural predictions are highly variable based on the algorithm used
due to the infancy of our knowledge regarding lncRNA secondary structure.
The interaction of lncRNAs with proteins is a well-known source of lncRNA
functionality, whether it is guiding chromatin modification enzymes or acting as molecular
scaffold. Several machine learning models have been developed to predict lncRNA protein
interactions from their sequences using k-mer based approaches. Using lncRNA and
protein sequence pairs to derive k-mers, the method RPISeq predicts lncRNA-protein
interactions with an accuracy of 80%, utilizing a support vector machine and random forest
(Muppirala, et al., 2011). LncPro predicts lncRNA-protein interactions using a structurebased approach, by first deriving structure-based features from the lncRNA and protein
sequences, which attains prediction accuracy similar to RPISeq (Lu, et al., 2013). The
structural features derived include vectors of hydrogen bonding, minimum energy
secondary structures and vectors of Van der Waal’s which are then transformed using a
Fourier transform to attain features of fixed length (Lu, et al., 2013). However, through the
addition of a stacked denoising autoencoder, a type of deep neural network, the IPminer
method was able to achieve an accuracy of 89% for lncRNA-protein interactions using
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only k-mers (Pan, et al., 2016). This accuracy is superior to that of RPISeq and the
structural based LncPro, suggesting that deep learning with k-mers is an optimal approach
for the prediction of lncRNA-protein interactions. In summary, lncRNA sequences appear
highly informative regarding their binding potential with DNA, RNA and proteins which
can provide insights into their biological function.

1.8 Concluding remarks
In this chapter, we have explored the functional roles of lncRNAs and their importance
in gene regulation especially in context of human neurodevelopmental disorders such as
ID and ASD. Furthermore, we briefly examined some genomic data mining methods for
lncRNA functional annotation based on their expression or primary sequences. In chapter
2, brain developmental coexpression networks are used to identify lncRNAs associated
biological pathways dysregulated in intellectual disability. In chapter 3, lncRNAs are found
to be differentially expressed in the ASD brain that are also highly co-expressed with ASD
risk genes in neuronal development. In chapter 4, a genetic algorithm is developed that
finds long sequence motifs in groups of lncRNA sequences. In chapter 5, a deep neural
network is constructed that predicts lncRNA subcellular localization directly from
transcript sequences.
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Abstract
The advent of next-generation sequencing for genetic diagnoses of complex developmental
disorders such as intellectual disability (ID) has facilitated the identification of hundreds
of predisposing genetic variants. However, there still exists a vast gap in our knowledge of
causal genetic factors for ID as evidenced by low diagnostic yield of genetic screening, in
which identifiable genetic causes are not found for the majority of ID cases. Most methods
of genetic screening focus on protein-coding genes, however, noncoding RNAs may
outnumber protein-coding genes and play important roles in brain development. Long
noncoding RNAs (lncRNAs) specifically have been shown to be enriched in the brain and
have diverse roles in gene regulation at the transcriptional and post-transcriptional levels.
LncRNAs are a vastly uncharacterized group of noncoding genes, which could function in
brain development and harbor ID predisposing genetic variants. We analyzed lncRNAs
for coexpression with known ID genes and affected biological pathways within a weighted
gene coexpression network derived from RNA-sequencing data spanning human brain
development. Several ID-associated gene modules were found to be enriched for lncRNAs,
known ID genes and biological pathways dysregulated in ID. Utilizing a list of de novo
and pathogenic copy number variants (CNVs), a major risk factor detected in ID probands,
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we identified lncRNAs overlapping these genetic structural variants. By integrating our
results, we have made a prioritized list of lncRNAs associated with ID based on a
coexpression network in the developing brain and genetic structural variants found in ID
probands.
2.1 Introduction
Intellectual disability (ID) is a developmental brain disorder characterized by
diminished intellectual function and adaptive behaviors, with an estimated prevalence in
the population between 1 and 3% (Leonard and Wen, 2002). Currently, in most cases of
ID an identifiable genetic cause is still unclear (Kaufman, et al., 2010). However, known
ID genes are predominantly involved in synaptic function such as cytoskeletal
reorganization and synaptic plasticity (Verpelli, et al., 2013). Disruptions in synapse
function likely cause a cascade of detrimental effects persisting into brain development,
indicating the necessity of the precise spatiotemporal gene expression required for normal
brain development. Genetic studies on ID have almost exclusively focused on variants in
protein-coding genes, such as copy number variants (CNVs) and single nucleotide variants
(SNVs). However, in human cells, the majority of RNA transcripts may not encode
proteins, suggesting the need to expand the search for causal factors of ID beyond proteincoding genes (Yoon, et al., 2014). In this study, we have examined over 4,000 long
noncoding RNAs (lncRNAs) to assess their potential association with ID through the
integration of RNA-sequencing data and genetic structural variants detected in ID affected
individuals.
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LncRNAs are longer than 200 nucleotides with diverse emerging regulatory
mechanisms; while some lncRNAs may encode small peptides, lncRNAs are vastly
untranslated (Slavoff, et al., 2013; Lander, 2014; Li, et al., 2014). Functionally, lncRNAs
have been shown to be involved in transcriptional and post-transcriptional regulation, in
addition to roles in epigenetic mechanisms (Schaukowitch and Kim, 2014). Specifically in
the brain, lncRNAs have been shown to be involved in neural differentiation and synaptic
plasticity (Wu, et al., 2013; Iyengar, et al., 2014; Schaukowitch and Kim, 2014). CNVs in
the genomic regions of these lncRNAs likely cause disruptive effects through alteration of
gene copy number, thereby leading to aberrant expression and possible downstream effects.
The identification of lncRNAs involved in neuronal and developmental processes which
are also affected by ID-predisposing CNVs may lead to the identification of novel ID
genes.
Considering the genetic heterogeneity of intellectual disability and largely
uncharted molecular roles of lncRNAs, we chose to construct a gene coexpression network
using RNA-seq data from the developing brain. This analysis facilitates the functional
annotation of uncharacterized lncRNAs by clustering genes based on correlations of
expression levels across brain developmental stages. Weighted gene coexpression network
analysis (WGCNA) is a well-established method for biological data mining (Langfelder
and Horvath, 2008). In previous studies, WGCNA has been used to elucidate convergent
molecular pathways, specific brain regions and developmental periods associated with
ASD, illustrating the functionality of coexpression networks for complex developmental
disorders (Voineagu, et al., 2011; Parikshak, et al., 2013; Liu, et al., 2014; Sugathan, et al.,
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2014; Ander, et al., 2015). Within a coexpression network, a module represents a group of
correlated genes, based on expression profiles, which likely share genetic regulation and/or
biological function. Thus, by clustering genes into coexpression modules, the biological
function of a lncRNA may be inferred from the Gene Ontology enrichment of the known
genes in the module and the degree to which the lncRNA correlates within the module. In
this study, the gene coexpression network is based on a comprehensive dataset of human
brain developmental transcriptomes. We compiled a list of known ID genes from multiple
sources, and used them to identify potential ID-associated lncRNAs in the coexpression
network. Moreover, we used a list of CNVs identified in a large cohort of probands with
ID to identify lncRNAs residing within the CNVs. This approach has facilitated the
prioritization of candidate ID-associated lncRNAs based on the developing brain gene
coexpression network seeded with known ID genes and disruptive genetic variants found
in ID probands.

2.2 Methods
Brain developmental transcriptome data
The BrainSpan developmental transcriptome dataset contains RNA-seq expression
profiles summarized to gene-level reads per kilobase million mapped reads (RPKM) with
GENCODE 10 annotations (Gardiner, 2015; Greenwood Genetic Center, 2015). Only
samples less than or equal to 3 post-natal years and from the neocortex were used in this
study. This resulted in 210 RNA-seq samples derived from 28 different individuals across
11 regions within the neocortex. LncRNAs were related to the genes of the developmental
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transcriptome by using the GENCODE v22 long noncoding RNA annotations. Genes were
variance-filtered by removing the lowest 25% of genes based on standard deviation. The
gene-level RPKM values were then normalized by using the log2 (RPKM+1) for all further
analysis.
Gene lists
The full ID gene list was compiled through the combination of three curated gene
sets, the “ID all” gene set by Parikshak et al, the XLID gene panel and the ID gene database
(Parikshak, et al., 2013; Gardiner, 2015; Greenwood Genetic Center, 2015) The ASD gene
list was obtained from the SFARI Human Gene Autism Database (Basu, et al., 2009). The
“ID only” gene list was created by removing genes from the full ID gene list that are also
classified as ASD genes. The “ID & ASD” gene set contains all overlapping genes from
the “ID all” and ASD gene list. The “XLID” gene set represents the XLID diagnostic panel
(Greenwood Genetic Center, 2015). All gene lists are provided in Additional File A-1.
Weighted gene coexpression network analysis
Signed weighted gene coexpression network analysis (WGCNA) was performed in
R, version 3.2.0, utilizing the WGCNA, v1.46, R package (Langfelder and Horvath, 2008;
R Core Team, 2015). Readers interested in the mathematical derivations of the technique
are

recommended

to

view

the

excellent

WGCNA

theory

website

(http://labs.genetics.ucla.edu/horvath/CoexpressionNetwork/). Traditional coexpression
networks are created by filtering a symmetric correlation matrix by a hard-threshold which
likely results in many false negatives due to the arbitrary cutoff of the threshold. WGCNA
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does not suffer from this pitfall due to utilization of a soft-threshold which simply
emphasizes high correlations. In addition, this soft threshold enables the coexpression
network to approximate scale-free topology, an inherent property of biological networks
(Albert, 2005). First, a correlation matrix, also known as a symmetric adjacency matrix,
was made by calculating the biweight midcorrelation, a robust alternative to the Pearson
correlation coefficient, between all gene pairs. This adjacency matrix was then raised to a
soft threshold power of 10 to achieve a scale free topology. The topological overlap
measure (TOM) is computed for all genes by taking into account direct pairwise
correlations as well as shared correlations between other genes. Gene modules were formed
by unsupervised clustering of genes of the hierarchical cluster tree based on the threshold
of dissimilarity, 1-TOM. The minimum module size was set at 50 genes with the module
merging cut height set at 0.20. The WGCNA results from this study are provided in
Additional File A-2.
Modular gene set enrichment analysis
For each gene set, we determined overrepresentation within each module using the
Fischer’s exact test. All resulting p-values from each gene set were adjusted by the false
discovery rate method, Benjamini-Hochberg correction (Benjamini and Hochberg, 1995).
We required an adjusted p-value of <0.05 and odds ratio of >1 to classify modular
enrichment of a specific gene list. Heatmaps of the –log10(adjusted P-value) were created
with the gplots R package (Warnes, et al., 2009). Results from the ID gene enrichment for
all modules are provided in Additional File A-3.
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CNV detection
CNV genomic coordinates were obtained from 213 idiopathic ID subjects using
array CGH analysis (Qiao, et al., 2013). We extracted the genomic coordinates of all
lncRNAs, from the human Ensembl assembly NCBI 37 using the R package “biomaRt”
(Durinck, et al., 2009). We performed genomic liftover, using the “rtracklayer” R package
for conversion to assembly NCBI 36 coordinates, to match the coordinates of the CNV
dataset (Lawrence, et al., 2009). All CNV overlaps were quantified using the
“GenomicRanges” R package (Lawrence, et al., 2013).
LncRNA candidate prioritization
The network plot was constructed by selecting the top two lncRNAs with the
highest modular membership values within each module that was statistically enriched for
the “ID Only” gene list. Modular membership is defined as the correlation of a genes
expression profile with the eigengene of the module. Next, for each of the chosen lncRNAs
we selected the top three most highly correlated genes based on connectivity. The network
plot was generated using Cytoscape v3.1.1 package by visualizing all biweight
midcorrelations above 0.65 (Shannon, et al., 2003). LncRNA prioritization was performed
by ranking all lncRNAs that overlapped a de novo or DECIPHER CNV by the maximal
absolute Pearson correlation coefficient to all genes in the full ID gene list. The full ranked
lncRNA list is available in Additional File A-4, including genomic location and type of
CNV overlap.
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2.3 Results and Discussion
Coexpression network analysis and identification of gene modules enriched with known ID
genes and lncRNAs
For weighted gene coexpression network analysis we utilized a comprehensive
developmental transcriptome dataset, which contains RNA-seq data from 210 neocortical
samples during early brain development (from 8 weeks post-conception to 3 post-natal
years). This developmental transcriptome dataset contains more than 50,000 genes,
including over 9,000 currently classified as lncRNAs. To reduce the search space for IDassociated lncRNAs, we chose to remove genes thought not to be involved in brain
development by filtering out genes with the lowest variance across the different stages
during brain development. After removing the bottom quartile of genes based on variance,
we retained a total of 39,000 genes, 6,000 of which are classified as lncRNAs. In addition,
we utilized high thresholds for module construction for further filtering, resulting in a final
gene coexpression network comprised of 26,030 genes including 4,070 lncRNAs, which
are distributed amongst 16 gene modules labeled by colors.
Next, we asked if the known ID genes converge onto specific coexpression
modules. Since coexpression implies shared function and/or regulation, ID-gene-enriched
modules would suggest that the genes in these modules are potentially involved in IDassociated biological pathways. We compiled a comprehensive list of known ID genes
(Additional File A-1) by combining gene lists from three curated sources, a diagnostic Xlinked ID gene panel, the ID gene database project and the ID gene list from a recent
publication (Parikshak, et al., 2013; Gardiner, 2015; Greenwood Genetic Center, 2015).
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Identification of ID-related modules also requires taking into account autism spectrum
disorders (ASD), which are present in up to 20% of ID cases (Kaufman, et al., 2010).
Utilizing the ASD gene list from the Simons Foundation Autism Research Initiative
(SFARI) Human Gene Database, we found our compiled ID gene list had a 20% overlap
with the ASD gene list (Basu, et al., 2009). This is not surprising because of the shared
genetic components between the disorders, such as the synaptic plasticity and transmission
pathways (Srivastava and Schwartz, 2014). To assess the enrichment of non-syndromic ID,
we created an ID-specific gene set, called “ID only”, by removing genes present in both
the ID and ASD gene lists, and the overlapping genes are referred to as “ID & ASD”.
By mapping the gene sets to the developmental coexpression network, we have
identified 2 out of 8 modules that are enriched for “ID only” genes without also being
enriched for “ID & ASD” genes or ASD genes (Figure 2.1 and Additional File A-2). These
two ID-specific modules are labeled as magenta and turquoise. The highest scoring term
of biological processes from Gene Ontology enrichment analysis for the turquoise module
is immune response (p-value < 0.001), whereas, the magenta module does not show any
significant functional term enrichment (Figure 2.2B). Interestingly, the blue, black and
purple modules are enriched for all four ID gene sets, in addition to the ASD gene list.
These modules are likely involved in core synaptic and regulatory pathways which are
affected in both ID and ASD. Gene Ontology functional analysis finds enrichment for
transcriptional regulation, synaptic transmission and protein localization, respectively
(Figure 2.2B). Furthermore, the blue, black, brown and turquoise modules possess a
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significant amount of lncRNAs (Additional File A-3), and thus are interesting modules to
examine the relationships between lncRNAs and known ID genes.

Figure 2.1 ID gene enrichment in coexpression modules. Overrepresentation of known ID
genes as a heat map displaying the –Log10 (adjusted P-values) of the Fischer’s exact test.
Odds ratio values are overlaid onto the heat map if they are greater than one. Only modules
with an adjusted p-value < 0.05 in at least one gene set are displayed resulting in 12 out of
the 16 modules shown.
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Figure 2.2 Characteristics of ID-gene-enriched coexpression modules. A) Gene
expression of lncRNAs from 2 months post-conception up to one post-natal year, grouped
by module, was normalized and plotted across developmental time using a scatter
smoothing function. The red line represents birth and the shaded adjacent regions of the
trend lines represent 95% confidence intervals. B) Modular gene enrichment was analyzed
using DAVID and the top 5 Gene Ontology terms of biological processes were displayed.
The red vertical lines represent the significance threshold of p-value= 0.01.

Besides modular functional annotation, we also examined the developmental
expression patterns of the co-expressed lncRNAs in these modules, which may be used to
infer biological function (Figure 2.2A). Interestingly, the two modules, turquoise and
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magenta, which are enriched specifically for non-syndromic ID genes, show a very similar
developmental expression trajectory. LncRNAs of both modules become highly expressed
in the late fetal period, a developmental period known for axonal and dendritic outgrowth
(Andersen, 2003). In contrast, the developmental expression profiles of the blue, black and
purple modules enriched for all ID gene sets show a mirrored developmental trend in which
they are down-regulated in the late fetal period and rise during the early post-natal stage
known for synaptic overproduction before the pruning stage (Andersen, 2003). The blue
module is enriched for transcriptional regulation, a known biological role of lncRNAs
(Additional file A-3). In addition, both the blue and black modules are also enriched for
synaptic transmission (both p-values < 0.00001). Interestingly, the expression patterns of
the modules enriched solely for ID genes and the modules enriched for all ID gene sets
appear to mirror each other, in terms of up- and down-regulation (Figure 2.2A). The fact
that these modules are enriched for ID genes, lncRNAs and known pathways in ID
disorders suggests that these modules are likely essential contributors to normal cognitive
development.

LncRNAs overlap with ID-associated CNVs
Next, we asked if lncRNAs could reside within CNVs and if those lncRNAs were
clustered into ID gene-enriched modules. To answer this question, we examined the
genomic overlaps of lncRNAs with CNVs observed in idiopathic ID from 213 probands
(Qiao, et al., 2013). Four subtypes of CNVs, including de novo, familial, common in ID
cases and common in controls, were experimentally classified (Qiao, et al., 2013). In
addition, a fifth subtype of known pathogenic CNVs associated with ID was added as a
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positive control from DECIPHER (Database of Chromosomal Imbalance and Phenotype
in Humans using Ensembl Resources) (http://decipher.sanger.ac.uk/). We found that the
lncRNAs within the turquoise, blue and brown modules had the highest number of genomic
overlaps with both the de novo CNVs and known pathogenic CNVs from DECIPHER.
These three modules had over three times the amount of ID-predisposing CNVs than the
gray module although the gray module is over two times the size of any other module. The
gray module contains genes that failed to merge with any other modules due to low
topological overlap. Thus, the gray module could effectively serve as a randomized control
for modular CNV overlap analysis.

Prioritization of candidate lncRNAs associated with ID
Focusing on modules which possessed features of ID gene enrichment and CNV
overlap, we asked whether lncRNAs residing in likely pathogenic CNVs were strongly coexpressed with known ID genes. We examined the coexpression network neighborhood of
the top CNV-harboring lncRNAs based on modular membership, of all ID enriched
modules, along with each lncRNAs most highly correlated genes (Figure 2.3). The blue
gene cluster contains two known ID genes, MBD5 and MEF2C, both of which are highly
co-expressed with lncRNAs residing in DECIPHER pathogenic CNVs. MBD5 is required
for methyl-CpG-binding specificity to methylated DNA, and haploinsufficiency of MBD5
is associated with intellectual disability (Williams, et al., 2009). Moreover, the expression
of the blue gene cluster is negatively correlated with developmental time, suggesting its
involvement in early neurodevelopmental processes. It is possible that these highly coexpressed lncRNAs may be involved in the transcriptional regulation of ID genes, such as
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MBD5 and MEF2C. In addition, disruptive CNVs affecting lncRNAs involved in
transcriptional regulation in the early fetal period could cause detrimental effects lasting
throughout neurodevelopment. The lncRNA CTC-467M3.1 is highly correlated with
MEF2C (Pearson’s correlation coefficient of 0.915). CTC-467M3.1 is located on the
antisense strand relative to MEF2C, suggesting the possibility that CTC-467M.3 might be
involved in the cis-regulation of MEF2C. Natural antisense transcripts (NATs) have been
shown to be involved in altering gene expression of their protein-coding counterparts,
typically by suppression at the epigenetic level, but their roles in transcriptional activation
and alternative splicing have also been observed (Vadaie and Morris, 2013). Thus, our
approach has found that lncRNAs can be highly co-expressed with known ID genes and
also overlap possibly pathogenic CNVs. These findings have allowed us to prioritize a list
of potential ID-associated lncRNAs for further analysis as candidates for novel ID genes
(Table 2.1). These lncRNAs reside within ID-predisposing CNVs and are ranked by the
highest correlation to known ID genes. Notably, the lncRNA CTC-467M3.1, is among the
top 15 ranked lncRNAs.
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Figure 2.3 Coexpression network plot of lncRNAs residing in ID-associated CNVs.
Network nodes represent genes, with the color being representative of the expression
correlation to developmental months. Red nodes show expression negatively correlated
with developmental months while green indicates positive correlation. The colored border
of the node indicates the module to which that gene belongs.

Table 2.1 Prioritized list of ID-associated lncRNA candidates. LncRNAs overlapping
pathogenic CNVs are ranked based on maximum correlation with known ID genes. The
lncRNA module assignment and correlation of expression to developmental age are also
provided.
Our results show the high coexpression between lncRNAs and known ID genes,
suggesting the association of lncRNAs with ID. This is the first time that an assessment of
associations between lncRNAs and ID has been performed on a genomic scale. However,
there have been a few specific lncRNAs associated with ID such as the lncRNA Evf2, also
known as DlX6-AS1, which is involved in a negative feedback loop of active chromatin
remodeling leading to transcriptional repression (Cajigas, et al., 2015). Interestingly,
mutations identified in Coffin-Siris syndrome (CSS), an intellectual disability, were found
to localize to components of the chromatin remodeling complex, such as DLX1, which
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upregulates DLX6-AS1 (Cajigas, et al., 2015). In our brain gene coexpression network,
DLX6-AS1 belongs to the blue module, which is enriched for transcriptional regulation.
Interestingly, DLX6-AS1 possesses the highest correlation (Pearson’s correlation
coefficient = 0.87) with DLX2, which has been shown to be functionally redundant to
DLX1 (Petryniak, et al., 2007).

2.4 Conclusion
In this study, we have identified potential ID-associated lncRNAs based on
coexpression with known ID genes. Some coexpression modules enriched for known ID
genes are also enriched for lncRNAs. The lncRNAs in these modules show specific
developmental expression patterns in the brain. We have observed two distinct expression
patterns of lncRNAs in ID-gene-enriched modules, showing inverse relationships most
noticeably with regards to the mid to late fetal period. The coexpression modules show
high level of connectivity between lncRNAs and known ID genes, affected pathways and
developmental periods. Moreover, we have identified lncRNAs residing within de novo
and pathogenic CNVs, which are major risk factors in ID. We have shown that lncRNAs
overlapping the CNVs are also highly co-expressed with known ID genes. For instance,
we have identified lncRNAs that show strong connections with MDB5 and MEF2C within
the brain gene coexpression network. Finally, we have prioritized the lncRNAs overlapping
ID-associated CNVs based on their coexpression to known ID genes in the developing
brain. This prioritized list was constructed through ranking lncRNAs by their maximal
correlation to known ID genes. The lncRNAs selected in this study can serve as a starting
point for a new direction of inquiry for expanding upon the causal genetic factors of ID.
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Abstract
Genetic studies have identified many risk loci for autism spectrum disorder (ASD)
although causal factors in the majority of cases are still unknown. Currently, known ASD
risk genes are all protein-coding genes; however, the vast majority of transcripts in humans
are noncoding RNAs (ncRNAs) which do not encode proteins. Recently, long noncoding
RNAs (lncRNAs) were shown to be highly expressed in the human brain and be crucial for
normal brain development. We utilize a novel computational pipeline for the integration of
various genomic datasets to identify lncRNAs associated with ASD. This method utilizes
differential gene expression patterns in affected tissues in conjunction with gene
coexpression networks in tissue matched non-affected samples. We analyzed RNA-seq
data from the cortical brain tissues from ASD cases and controls to identify lncRNAs
differentially expressed in ASD. We derived a gene coexpression network from an
independent human brain developmental transcriptome and detected a convergence of the
differentially expressed lncRNAs and known ASD risk genes into specific coexpression
modules. Coexpression network analysis facilitates the discovery of associations between
previously uncharacterized lncRNAs with known ASD risk genes, affected molecular
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pathways and at-risk developmental time points. In addition, we show that some of these
lncRNAs have a high degree of overlap with major CNVs detected in ASD sequencing
studies. By utilizing this integrative approach comprised of differential expression analysis
in affected tissues and connectivity metrics from a developmental coexpression network,
we have prioritized a set of candidate ASD-associated lncRNAs. The identification of
lncRNAs as novel ASD susceptibility genes could help explain the genetic pathogenesis of
ASD.
3. 1 Introduction
Autism spectrum disorder (ASD) is a group of highly heritable genetic neurodevelopmental
disorders characterized by impaired social communications with an estimated prevalence
of 1 out of 68 births in 2010 (CDC, 2014). ASD risk genes include hundreds of proteincoding genes most commonly affected by copy number variants (CNVs) which can perturb
gene expression; however, each known ASD risk gene only accounts for less than a few
percent of ASD cases (Leblond, et al., 2014; Yu, et al., 2015). Most of these ASD risk
genes function in several biological pathways, such as synaptic transmission,
transcriptional regulation, immune response and chromatin remodeling (Garbett, et al.,
2008; Voineagu and Eapen, 2013; De Rubeis, et al., 2014; Ander, et al., 2015). ASD is
highly heterogeneous and there is still unaccounted genetic risk factors that likely resides
outside protein-coding regions such as in regulatory noncoding RNAs (ncRNAs).
Long noncoding RNAs (lncRNAs) are transcripts greater in length than 200
nucleotides, which do not encode proteins. LncRNAs have been shown to be involved in a
diverse array of neurodevelopmental functions such as brain development, neural
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differentiation and synaptic plasticity (Wu, et al., 2013; Iyengar, et al., 2014; Schaukowitch
and Kim, 2014; Briggs, et al., 2015). LncRNAs can also have epigenetic functions by
interacting with chromatin re-modeling complexes to facilitate gene silencing or activation
(Nie, et al., 2012; Schaukowitch and Kim, 2014). In addition, lncRNAs function in brain
development, contributing to increased cognitive function and neuronal tissue specification
(Clark and Blackshaw, 2014). Other than epigenetic functions, studies have shown lncRNA
regulatory actions through diverse mechanisms such as multi-protein scaffolding,
transcriptional interference, post-transcriptional modification and miRNA blocking
(Geisler and Coller, 2013). The functionalities of lncRNAs to negatively or positively
affect gene expression at the transcriptional, post-transcriptional, translational and
epigenetic levels exhibit their regulatory versatility. In addition, because lncRNAs are
highly tissue-specific and highly expressed in the human brain, lncRNAs are likely
involved in complex neurodevelopmental disorders such as ASD (Wilkinson and
Campbell, 2013; Wu, et al., 2013; Ziats and Rennert, 2013; Clark and Blackshaw, 2014;
Wang, et al., 2015).
Microarray gene expression profiling of the ASD cortex indicated that the number
of differentially expressed lncRNAs between the prefrontal cortex and cerebellum in ASD
brains was lower than between the same brain regions in controls (Ziats and Rennert,
2013). This paradigm has also been observed in other studies in the ASD cortex with
regards to mRNA expression and differentially methylated regions (Voineagu, et al., 2011;
Nardone, et al., 2014). These studies suggest that ASD may be caused by aberrant
neurodevelopment which could dysregulate neuronal tissue-specification. In a differential
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expression analysis of ASD leukocytes, more lncRNAs were found to be differentially
expressed than mRNAs, including thirteen lncRNAs associated with synaptic functions
(Wang, et al., 2015). Genetic lesions of these lncRNAs, such as by CNVs, can impair gene
expression and/or regulation which could have downstream regulatory consequences
affecting neurodevelopment (Vincent, et al., 2010; Lin, et al., 2011; Vondervoort, et al.,
2013; Zhubi, et al., 2014).
Our goal is to find differentially expressed lncRNAs in the ASD cortex and then
identify which lncRNAs are also highly co-expressed with known ASD risk genes and
ASD-affected biological pathways in neurodevelopment. The reasoning for using
coexpression networks is that lncRNAs are vastly functionally uncharacterized, therefore,
highly correlated gene and lncRNA expression patterns across developmental time imply
shared biological function and/or regulation. Coexpression allows us to refine our list of
candidate ASD-associated lncRNAs through gained functional insights utilizing this
expression-based guilt-by-association heuristic. We have utilized an integrative approach
for identifying ASD-associated lncRNAs, by analyzing differentially expressed lncRNAs
in the ASD cortex and mapping them onto a brain developmental gene coexpression
network. This approach, despite the genetic heterogeneity of ASD, facilitates the
identification of ASD-associated lncRNAs by leveraging the information of ASD and nonASD developmental cortex transcriptomes.
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3.2 Results and Discussion
Differential expression of lncRNAs in the ASD cortex
We speculated that genes differentially expressed in the ASD cortex would be
informative for identifying ASD-associated lncRNAs because the human cortex has been
implicated in ASD pathophysiology by multiple transcriptomic studies (Parikshak, et al.,
2013; Willsey, et al., 2013). Therefore, we re-analyzed RNA-seq data from the ASD cortex
from a previous independent study which focused on differential splicing of protein-coding
genes, yet did not analyze lncRNAs (Voineagu, et al., 2011). We found 1602 differentially
expressed genes (FDR adjusted p-value < 0.05; | Log2 fold change | ≥ 1) (Figure 3.1).
Furthermore, genes significantly down-regulated in the ASD cortex were enriched for
biological processes related to synaptic function such as chemical synaptic transmission
and synaptic signaling (p-values < .001) (Additional File A-5). The up-regulated genes
were enriched for biological functions such as immune system process, cell surface
receptor signaling pathway and response to cytokines (p-values < .001) (Additional File
A-5). These results are in concordance with previous findings from ASD brain gene
expression studies, where genes functioning in the synaptic transmission pathway were
down-regulated, while genes involved in immune response were upregulated (Voineagu
and Eapen, 2013). Furthermore, known ASD risk genes, curated by the Simons Foundation
Autism Research Initiative (SFARI), were enriched within the differentially expressed
genes (p-value < .001) (Additional File A-5) (Basu, et al., 2009). Thus, differentially
expressed genes in the ASD cortex appear to be representative of known ASD
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pathophysiology based on enrichments of biological pathways dysregulated in ASD and
overrepresentation of known ASD risk genes.

Figure 3.1 Differentially expressed genes in the ASD cortex. Volcano plot displaying
genes differentially expressed in the ASD cortex. A gene was required to have an
absolute value of log2 fold change greater than or equal to one and an adjusted p-value
less than 0.05 to be considered differentially expressed.

Interestingly, we detected 263 lncRNAs differentially expressed between ASD and
control cortical brain samples (FDR adjusted p-value < 0.05; |Log2 fold change| ≥ 1)
(Additional File A-7). Almost half of these differentially expressed lncRNAs were from
intergenic regions (45%), with most of the remaining lncRNAs antisense to protein-coding
genes (41%) (Additional File A-8). Next, we identified the nearest neighboring gene to
each lncRNA since lncRNAs can have cis-regulatory mechanisms; remarkably, 5 of these
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lncRNAs are antisense to known ASD risk genes such as RAPGEF4, DLX6, STXBP5,
KLC2 and DMXL2 (Additional File A-8).
Next, we asked if these lncRNAs are specifically expressed in the human brain
relative to other tissue types, which would suggest brain-specific biological functions. We
extracted RNA-seq data from the Genotype-Tissue Expression project for over 40 different
human tissues, each containing over 50 samples, and plotted the median expression of the
differentially expressed lncRNAs for each tissue (Lonsdale, et al., 2013) (Additional
Figure B-1). The majority of these lncRNAs are highly expressed in brain tissues relative
to other tissue types (Additional Figure B-1). Furthermore, we found that the tissue type
with the highest average expression for these lncRNAs is the brain cortex, suggesting that
these lncRNAs perform cortex associated biological functions (Additional Figure B-1). We
now have a list of lncRNAs differentially expressed in the ASD cortex, of which
approximately 50% of the lncRNAs have a fractional expression level greater than 50% in
the human brain suggesting tissue-specificity (Additional File A-8). We further refine the
list of candidate lncRNAs through coexpression network analysis.
Gene coexpression network analysis indicates that differentially expressed lncRNAs are
involved in biological processes dysregulated in ASD
We built genome-wide gene coexpression networks by utilizing the BrainSpan
developmental transcriptome dataset, which consists of brain samples from eight weeks
post-conception up to 40 years of age (Brainspan, 2013). First, we extracted all samples
within cortical brain regions and then filtered out lowly expressed genes. This preprocessing resulted in a final RNA-seq dataset consisting of 352 cortical brain samples and

46

26,188 genes, of which 127 out of the 263 differentially expressed lncRNAs were present.
Next, we used this refined RNA-seq dataset for signed weighted gene coexpression
network analysis (WGCNA) (Langfelder and Horvath, 2008) which identified 33 gene
coexpression modules (Additional File A-7). These coexpression modules symbolize
groups of genes with similar developmental expression profiles through cortical
development. Measuring the coexpression of randomly sampled groups of genes of equal
size to each module shows that these coexpression modules are all significantly coexpressed (Additional Figure B-2).
Next, we asked if there were modules enriched for both differentially expressed
lncRNAs and known ASD risk genes. To assess gene enrichment of ASD risk genes within
modules, we utilized two independent lists of ASD risk genes. The list referred to as SFARI
has been curated by the Simons Foundation Autism Research Initiative (SFARI) and these
genes are scored based on the degree and strength of evidence for implications in ASD
(Basu, et al., 2009). To avoid any bias in the SFARI gene set, which is manually curated,
we also utilized a gene list known as the ME16 module which was identified in an
independent unsupervised genome-wide coexpression study in brain tissue (Parikshak, et
al., 2013). The ME16 gene list was shown to be enriched for genes with rare de novo
genetic variants in ASD probands and a gene list known as “asdM12”, which contains
genes aberrantly expressed in the ASD cortex (Voineagu, et al., 2011; Parikshak, et al.,
2013). The differentially expressed lncRNAs show statistical enrichment in three modules
(Blue, Brown and Black) (Figure 3.2). Interestingly, the Blue module is also enriched for
SFARI ASD risk genes and ME16 genes (Fig 3.2). The co-enrichment of two ASD gene
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sets and lncRNAs differentially expressed in the ASD cortex within the same
developmental brain coexpression module suggests that the Blue module and the lncRNAs
within it, are likely functionally involved in ASD pathogenesis.

Figure 3.2 Enrichment of lncRNAs and ASD genes in brain developmental coexpression
modules. Heatmap showing module based enrichment of gene lists, “DE LncRNAs” are
lncRNAs differentially expressed in the ASD cortex, “SFARI ASD” are known ASD risk
genes and “ME16” is an ASD-associated gene coexpression module identified in an
independent study. Enrichment of gene lists was determined by a Fischer’s exact test
requiring the FDR-adjusted p-value < 0.05 and an Odds Ratio > 1. Only modules
containing at least 1 differentially expressed lncRNAs are shown.

Next, we asked if the identified coexpression modules were dysregulated in ASD
by assessing their average differential expression in the ASD cortex of each module. Since
we have identified less than two thousand differentially expressed genes in the ASD cortex
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and there are over 26,000 genes in our developmental coexpression network, the vast
majority of genes in the network have an ASD cortical fold change of zero (log2 fold
change). Therefore, modules which show a statistically significant average ASD foldchange which deviates from zero likely represent biological pathways dysregulated in
ASD. When overlaying the differential expression fold changes calculated from the ASD
cortex onto the coexpression modules, 13 out of the 33 modules were found to be
significantly differentially expressed on average compared to randomly sampled gene sets
of the same size (Figure 3.3). Interestingly, all modules enriched for lncRNAs are on
average differentially expressed in ASD, with the Blue module showing down-regulation
while the Brown and Black modules are up-regulated (Figure 3.3). This suggests common
mechanisms dysregulating these ASD-associated gene networks. Next, we examine the
functional enrichments of these ASD-associated modules.

49

Figure 3.3 Differential expression in the ASD cortex overlaid onto developmental
coexpression modules. Average log2 fold changes of genes differentially expressed in the
ASD cortex were overlaid onto the coexpression modules formed using the BrainSpan
Developmental Transcriptome. Any genes that failed to reach significance had their log2
fold changes set to 0. The red circle within each bar plot is the average log2 fold change
of 10,000 random gene samplings of equal size to the respective module. Significance of
differential expression compared to the permuted distribution (FDR < 0.05) is denoted by
a black asterisk adjacent to a modules respective bar plot.
We functionally characterized all modules enriched for differentially expressed
lncRNAs by performing Gene Ontology Enrichment Analysis and visualizing their
developmental expression pattern in the human cortex (Figure 3.4). The Blue module’s top
three enriched biological processes are synaptic signaling, chemical synaptic transmission
and anterograde trans-synaptic signaling (p-values < .001) (Figure 3.4). The synaptic
transmission pathway is a well-known biological process dysregulated in ASD from gene
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expression and genome-wide association studies (Voineagu, et al., 2011; Berg and
Geschwind, 2012; Parikshak, et al., 2013; Voineagu and Eapen, 2013; De Rubeis, et al.,
2014; Srivastava and Schwartz, 2014). Moreover, the expression of the genes within the
Blue module show a positive correlation with developmental time in the cortex (Pearson’s
correlation coefficient, R2 = 0.55) (Figure 3.4), possibly coinciding with major cortical
development (Parikshak, et al., 2013). The Brown and Black modules, which are only
enriched for differentially expressed lncRNAs, have functional enrichments for immune
response and lipid transport, respectively (Figure 3.4). Perturbations in the immune system
as well as the transport of fatty acids has also been associated with ASD (Shimamoto, et
al., 2014; Nazeen, et al., 2016). Remarkably, the differentially expressed lncRNAs are
enriched in modules which have all been functionally linked with ASD, the synaptic
transmission, immune response and lipid transport pathways (Qiu, et al., 2006; Garbett, et
al., 2008; Voineagu and Eapen, 2013; De Rubeis, et al., 2014; Shimamoto, et al., 2014).
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Figure 3.4 Characterization of modules enriched for differentially expressed lncRNAs.
Gene ontology functional enrichments were performed for each module and adjusted for
multiple comparisons (FDR < 0.05). The scatterplots show modular developmental
expression profiles based on a modules eigengene (1st principal component) through
developmental time, months PC means months post-conception (2 months post-conception
to 1 post-natal year), with the blue vertical line demarcating birth. The trend line of each
scatterplot is derived from a locally weighted scatterplot smoothing function.

Prioritization of candidate ASD-associated lncRNAs
The gene ontology enrichments and developmental expression trajectories (Figure
3.4) are representative of entire coexpression modules, however the differentially
expressed lncRNAs represent a minority of the total genes within the modules. To assess
the direct relationships between lncRNAs and ASD risk genes we examined the
coexpression solely between lncRNAs and ASD risk genes compared to random
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permutations. In both ASD gene sets, SFARI and ME16, we find statistically significant
(p-values < .0001) summed correlations directly between the differentially expressed
lncRNAs and ASD gene sets relative to randomly sampled gene sets (Additional figure B3). These results further suggest that the identified lncRNAs are involved in the similar
convergent biological processes dysregulated in ASD.
All the evidence presented thus far has been expression-based; therefore, we
speculated that the integration of genetic mutational data, such as ASD-associated CNVs
would be beneficial for the ranking of candidate ASD-associated lncRNAs.

We

incorporated a list of 5,030 major ASD-associated CNVs curated by SFARI from ASD
genetic sequencing studies and calculated overlaps for all genes in the developmental
network. To prioritize differentially expressed lncRNAs, we ranked the lncRNAs based on
their module assignment to prioritize lncRNAs in modules enriched for ASD risk genes
followed by ranking lncRNAs within the same module by their total overlaps with ASDassociated CNVs. Interestingly, the highest ranked lncRNA, HTR5A-AS1, is highly brain
specific and its most highly correlated gene in the network is AGBL4, a known ASD risk
gene which is also down-regulated in the ASD cortex (Pearson correlation = 0.98)
(Additional file A-8). A summary of the genomic characteristics and coexpression network
results for the candidate ASD-associated lncRNAs identified here, grouped by module, are
presented in (Figure 3.5) including the total ASD CNV-lncRNA overlaps detected. In
summary, we observe the largest amount of the DE lncRNAs in the blue, black and brown
modules (Figure 3.5A), where the lncRNAs in the blue module are heavily down-regulated
in the ASD cortex while the lncRNAs in the black and brown modules are up-regulated
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(Figure 3.5B). Furthermore, the lncRNAs in the blue and black modules due on average
exhibit tissue-specificity to the human brain relative to all tissue types (Figure 3.5C). In
addition, the lncRNAs of the blue module show the highest level of ASD CNV overlaps
(Figure 3.5D), suggesting these lncRNAs may be affected by CNVs in ASD.
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Figure 3.5 Candidate ASD-associated lncRNA characteristics.
(A). Module assignment for DE lncRNAs, only modules with at least 3 lncRNAs are
displayed, in addition we provide the module function which is the highest scoring gene
ontology biological process for the whole module. (B) Average log2 fold change, from the
ASD cortex, of the DE lncRNAs in each module. (C) Average fractional expression levels
in the brain of the DE lncRNAs in each module. Fractional brain expression for each
lncRNA is calculated from the Genotype Tissue expression project RNA-seq data, as the
total expression in brain tissues divided by the sum of expression across all tissue-types
(Lonsdale, et al., 2013). The red line at 50% represents the threshold for tissue-specificity
as defined by Ayupe et al (Ayupe, et al., 2015). (D) Total overlaps between ASD CNVs
and DE lncRNAs in each module.
For each differentially expressed lncRNA we also identified its most highly coexpressed protein-coding gene within the developmental network. Remarkably, fourteen
candidate ASD-associated lncRNAs most highly co-expressed genes, in a network of over
21,000 genes, are known ASD risk genes (Additional file A-8). This result indicates these
lncRNAs are likely involved in the molecular function and/or regulation of these specific
ASD risk genes. However, further experimental studies will be needed to decipher the true
relationship between these candidate ASD-associated lncRNAs and their highly coexpressed ASD risk genes. This prioritized list of ASD-associated lncRNAs can assist
geneticists by providing high-quality novel experimental targets to further elucidate ASD
pathogenesis.

3.3 Conclusions
Utilizing differential expression analysis in affected tissues coupled with an
independent developmental gene coexpression network, we have identified a list of
candidate ASD-associated lncRNAs. These lncRNAs are differentially expressed in the
ASD cortex, highly expressed in brain and cortical tissues and also co-expressed with ASD
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risk genes in the developing cortex. We have identified a coexpression module enriched
for both differentially expressed lncRNAs and ASD risk genes; this module is functionally
enriched for the synaptic signaling and transmission pathways. In addition, two modules
were enriched solely for differentially expressed lncRNAs, which were functionally
enriched for the immune response and lipid transport pathways, biological processes
suspected to be dysregulated in ASD. Furthermore, all modules enriched for lncRNAs are
on average significantly differentially expressed in the ASD cortex, with the synaptic
module showing down-regulation and the immune and lipid transport modules being upregulated. Finally, we identified 14 lncRNAs whose most highly co-expressed genes in the
entire network are known ASD risk genes suggesting direct functional associations. The
convergence of the independent genomic results presented here suggest an association
between these previously uncharacterized lncRNAs and ASD in the human brain. These
lncRNAs can serve as prioritized candidate ASD risk genes to expedite future genetic
studies researching ASD pathogenesis.

3.4 Methods
RNA-seq data analysis
We extracted raw RNA-sequencing data from human cortical tissues for three ASD
cases and controls, each with two technical replicates, from a published study (GEO
accession GSE30573) (Voineagu, et al., 2011). Transcript abundances were quantified
from RNA-seq reads which were mapped to the human transcriptome version GRCh38
with gene annotations from ENSEMBL v86, using Salmon (v0.7.1) (Patro, et al., 2017).
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Transcript counts were then imported into R (version 3.3.2) using tximport (R package,
v1.2.0) (Soneson, et al., 2015). All subsequent analyses were performed in R (version
3.3.2) on a 64-bit Windows 7 system.
Differential expression analysis
Differential expression was performed based on the difference in gene counts between
ASD cases and controls using DESeq2 (R package, v1.10.1) (Love, et al., 2014). DESeq2
estimates differential expression using a negative binomial model which have been shown
to be reduce false positives compared to other methods (Z. H. Zhang, et al., 2014). A gene
was considered differentially expressed if it had an FDR-adjusted p-value less than 0.05
and an absolute log2 fold change greater than or equal to one.
Tissue-specific expression of lncRNAs
We downloaded the tissue-specific RNA-seq dataset, in which gene-level median
RPKM abundances are reported for each tissue type, from the Genotype-Tissue Expression
(GTEx) program (Lonsdale, et al., 2013).We filtered the data to remove any tissue types
with less than 50 samples. For each differentially expressed lncRNA, FPKM values were
Z-score normalized across the tissues then plotted in a heatmap using the gplots (R
package, v3.0.1) (Warnes, et al., 2009). Hierarchical clustering was performed on the
tissues and all brain tissues were highlighted blue using a color key. Fractional brain
expression is calculated by the summation of all expression values in brain tissues divided
by the total expression for all tissue-types multiplied by 100 to get a relative percent.
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Gene lists
The “DE lncRNA” gene list is composed of all significant differentially expressed
genes which have lncRNA biotypes according to Ensembl (v84). The ASD gene list was
extracted from AutDB, the SFARI human gene database (Basu, et al., 2009). We utilized
the SFARI “Gene Score”, which categorizes ASD risk genes based on evidence for
implication in ASD, to filter the ASD risk genes. The “SFARI” gene list is only composed
of genes with evidence levels 1-5 (high evidence– minimal evidence). We obtained M16
from an independent genomics study which applied WGCNA to the BrainSpan
developmental RNA-seq dataset to identify modules in the developing brain enriched for
ASD risk genes (Parikshak, et al., 2013).
Cortical development expression data
We downloaded the BrainSpan Developmental transcriptome Gencode v10 dataset
(summarized to gene-level reads) from http://www.brainspan.org/. Only samples from
cortical brain regions were used in our analysis and we used a variance filter to remove the
bottom two quartiles of genes based on across sample variance. This preprocessing resulted
in an RNA-seq dataset with 352 cortical samples and 26,188 genes which was used as input
for gene coexpression network analysis.
Coexpression network analysis
Coexpression networks were built using WGCNA (R package, v1.51) (Langfelder
and Horvath, 2008). The biweight midcorrelation, a correlation metric more robust to
outliers than the Pearson correlation, was used to calculate correlations between all gene
pairs. Afterwards, a signed weighted network was created using a soft-threshold power of
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12 to approximate network scale-free topology. Next, the topological overlap was
calculated between all gene pairs. The topological overlap metric represents not only pairwise relationships, but relationships between cliques of genes and is therefore
advantageous for clustering genes over pair-wise methods. To identify coexpression
modules a hierarchical cluster tree is created based on the topological overlap matrix, with
modules representing distinct branches of the dendrogram. Modules are formed from the
result of a dynamic tree cutting algorithm (Langfelder and Horvath, 2008). All parameters
used for network construction are included in (Additional file A-5).
Network validation
To validate that all modules were co-expressed above what would be expected by
random chance, we performed a coexpression permutation test. This was done by assessing
the average correlation of randomly sampled gene sets, which were equal in size to the
modules derived previously, 10,000 times. Comparing the distributions of the average
biweight mid-correlation of randomly sampled gene sets with the coexpression of each
module, we found all modules to be significantly co-expressed above random chance
(modules, p < 1x10-4).
Next, we asked if the up- and down-regulated genes that we identified in the ASD
brain segregated into the developmental modules created using BrainSpan (Brainspan,
2013). We performed another permutation test where we calculated the average log2 fold
change of 10,000 randomly created gene sets equal in size to each module and then
compared these distributions to each module’s average log2 fold change in the ASD brain.
Gene set enrichment analysis
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Overrepresentation of gene lists within modules was calculated using a one-sided
Fisher exact test to assess gene list enrichment. All p-values, from all gene sets and
modules, were adjusted for multiple testing using the False Discovery Rate method
(Benjamini and Hochberg, 1995). We required an odds ratio > 1 and an adjusted p-value <
0.05 to claim a gene set is enriched within a module. The –log10( p-values) was then plotted
in a heatmap using the gplots (R package, v3.0.1) (Warnes, et al., 2009).
Module characterization
Gene Ontology enrichment analysis in each lncRNA-enriched module was
characterized using the GOstats (R Package, v2.36), reported biological processes were
required to have an FDR-adjusted p-value < 0.05 (Falcon and Gentleman, 2007). Module
eigengenes, representing module developmental trajectories, from 8 weeks postconception to 1 post-natal year were plotted and fitted with a locally weighted scatterplot
smoothing function using ggplot2 (R package, v2.1.0) (Wickham, 2009).
LncRNA-ASD risk gene coexpression analysis
The summation of all biweight midcorrelations between differentially expressed
lncRNAs with SFARI or ME16 genes was calculated. Next, the summed correlation
between lncRNAs and randomly sampled gene sets, of equal size to the respective ASD
gene list was calculated 10,000 times. This resulted in a permuted normal distribution from
which a p-value was derived for the actual summed correlation between the lncRNAs and
ASD gene sets.

CNV analysis
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CNV summary data was downloaded from SFARI and filtered to only retain CNVs
with a report class of “Major” (Abrahams, et al., 2013). Using the cytoband locus we
converted all CNVs into hg38 genomic coordinates according to the hg38 cytoband
coordinates from UCSC (Additional file A-5). Overlaps were quantified for each gene if
its genomic coordinates overlapped the CNV range using the GenomicRanges (R package,
v1.22.4) (Lawrence, et al., 2013).
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Abstract
Long noncoding RNAs (lncRNAs), each with >200 nucleotides in length, constitute a
large portion of the human transcriptome. Although recent studies indicate that lncRNAs
play key roles in gene regulation, development and disease, the RNA functional motifs are
still poorly understood. Most of the existing algorithms for motif finding are severely
limited in scalability with regards to sequence and motif size. In this study, we propose a
novel genetic algorithm for discriminative motif identification capable of handling large
input sequences and motif sizes by utilizing genetic operators to learn and evolve in
response to the input sequences. We utilize our method on long noncoding RNA (lncRNA)
transcripts as a test case to identify functional motifs associated with subcellular
localization. Our methodology shows high accuracy and the ability to identify functional
motifs associated with subcellular localization in lncRNAs, which recapitulates a previous
experimental study.
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4. 1 Introduction
The identification and subsequent functional annotation of short reoccurring motifs
within molecular sequences has been integral for the field of genetics. Generally, the first
step regarding functional annotation of a novel protein or RNA sequence is the
identification of known functional motifs within the primary sequence. Once identified,
these motifs allow the functional inference of the previously uncharacterized sequence.
Functional motifs are generally identified assuming a random uniform background
nucleotide model, however the nucleotide sequence within a gene are not randomly
distributed, but have structure; therefore, the utilization of real sequences as a background
set is advantageous. The use of a positive and negative sequence set is known as
discriminative motif identification. Popular algorithms for discriminative motif discovery
include discriminative regular expression motif elicitation (DREME) (Bailey, 2011).
However, the DREME algorithm suggests input sequences are less than 500 nucleotides
and that the motif width is less than or equal to 8 nucleotides.
Recently, tens of thousands of long noncoding RNAs (lncRNAs) have been discovered
in primates, the vast majority of which are functionally uncharacterized. LncRNAs are
poorly conserved across species and can perform a myriad of diverse functions, adding to
the complexity of their functional annotation. Unlike mRNAs, lncRNAs can localize in
many different places within the cell, which can provide insights into their functionality.
Localization motifs have been identified in lncRNA transcripts which regulate subcellular
localization. Thus it may be possible to identify motifs within lncRNA transcripts, genome-
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wide, associated with subcellular localization, providing a valuable first step in the
functional annotation of human lncRNAs. One method to do this would be to identify two
distinct sets of lncRNAs, one enriched in the cytoplasm and the other enriched in the
nucleus, followed by finding motifs overrepresented in one set of transcripts but not the
other. However, there are tens of thousands of human lncRNAs, which have a median
transcript length of 592 bp and could possibly contain long functional motifs (Derrien, et
al., 2012). Due to these issues and limitations, previous approaches are unsuitable for our
purposes of the identification of functional motifs in full length lncRNAs genome-wide.
Genetic algorithms, which mimic biological evolution to stochastically evolve a
population of solutions over time, have been utilized for motif finding previously, such as
MDGA (Che, et al., 2005). MDGA represents a solution as a vector of indices which
indicate the starting position of the motif in each sequence and therefore fail to utilize all
the information present in a sequence, such as multiple motif occurrences. Furthermore, all
the methods mentioned previously were developed for the identification of transcription
factors binding sites, which are small motifs and are contained in very short sequences,
such as ChIP-Seq peaks (< 100 nucleotides). We propose to develop a novel genetic
algorithm (GA) for discriminative motif discovery to identify long functional motifs in
full-length lncRNA transcripts, a use-case previous methods are incapable of.
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4.2

Methods

Representation and Population Initialization
We represent a solution as a position weight matrix (PWM) of length w, which is
therefore not dependent on the input sequence size. A fixed number of individuals is
initialized to derive a population by creating randomized PWMs utilizing the conjugate
dirilecht distribution.

Fitness
The fitness function must identify similar sequence motifs in the positive set which are
underrepresented in the negative set. A useful metric for the identification of informative
similar sequences is the information content (IC), the total information content of a PWM
M is as follows (Shannon, 1948).

𝐼𝐶(𝑀) = ∑𝑤
𝑖=1 ∑𝛽∈{𝐴,𝐶,𝐺,𝑇} 𝑀𝛽𝑖 log 2

𝑀𝛽𝑖
𝑝𝛽

(1)

Where W is the motif width, 𝑴𝜷𝒊 is the frequency of nucleotide β of column i and 𝒑𝜷 is
the background probability of nucleotide β. We chose to augment this popular metric to
incorporate our goal of minimizing the matches of the PWM in the negative sequence set.
We define the fitness score to be the information content of the PWM divided by the total
−
matches of the PWM in a small random subset 𝑺−
𝜷 of negative set 𝑺 .

𝐹𝑖𝑡𝑛𝑒𝑠𝑠 =

𝐼𝐶(𝑀)
∑𝑆∈ 𝑆− 𝜎𝑀 (𝑆)
𝜷
(
)
|𝑆−
𝜷|

65

(2)

Where 𝜎𝑀 (S) equals the match score of motif M in sequence set S and |𝑺−
𝜷 | is the total
sequence length scanned, used as a normalization factor. Using a sliding-window across
each sequence we calculate a score as the log-likelihood PWM score divided by the
maximal PWM score.

Selection
During each iteration, selection occurs to determine which solutions survive into the
next generation. A solution’s probability of survival is approximately proportional to their
fitness score. Linear-rank selection then occurs with replacement to generate a new
population of solutions.

Crossover and Mutation
Crossover occurs by randomly selecting two parent individuals which are then
recombined to create two novel children solutions. Therefore, crossover allows the
recombination of solutions to further explore the solution space. To avoid the positional
bias of the traditionally used 1-point crossover, we chose to utilize random uniform
crossover. In random uniform crossover, we randomly choose a crossover number c
between (w+1: w-1), then we randomly select c columns of the parental solution PWMs to
be switched. The resulting children solutions then replace the initial parental solutions used
for crossover.
Mutation occurs by randomly selecting solutions which are then altered stochastically
to allow further exploration of the search space, thereby avoiding local maxima. For each

66

solution M selected for mutation, we randomly select a fixed proportion β of the positive
sequence set S+, then we score the solution across all possible windows of the sequences
+
in 𝑺+
𝜷 . Based on the maximal scoring position of M in each sequence of 𝑺𝜷 we then update

the PWM to form M’ using the alignment of the selected positions.

Implementation
The program was implemented in the R statistical language utilizing the framework
from the R package GA [7,8]. The pseudo-code is as follows:
1. Set Input Parameters:
S = Full sequence set ordered by positive/negative
W = Motif Width; P = Population size; i = 0
R = Number of generations to terminate if best solution not improved
2. INITIALIZE Population: Randomly create P PWMs
3. Fitness EVALUATION: BEST = max(Fitness(P))
4. Genetic Operators: While (i < R)
ELITISM: Save top 5% of fittest solutions for next generation
SELECTION: Linear-rank selection to create new P
Random uniform CROSSOVER of random subset of P
MUTATE random subset of P
Evaluate fitness of new P
TERMINATION: If ( max(fitness(P)) == BEST) {
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i = i +1 } else {
BEST = max(Fitness(P))
i=0 }

4.3 Results
To evaluate our genetic algorithm (GA) we first begin with synthetic data in order to
obtain complete control over the sequence attributes. We created a set 𝑺+ of 100
independent and identically distributed sequences over a range of lengths with a single
randomly implanted motif of length 15, each with 3 random mutations per sequence. Our
negative sequence set 𝑺− is simply a dinucleotide shuffle of 𝑺+ . To assess the sensitivity
of the GA we evaluate its performance over a large range of different sequence lengths N,
because as N increases the noise to signal ratio increases (Figure 4.1).
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Figure 4.1. Motif Identification Accuracy. Motif similarity is represented by the loglikelihood PWM score divided by the maximal log-likelihood PWM score, averaged over
11 trials for each of the different sequence lengths. The red line is the threshold for a
significant match as defined by Hansen (Hansen, et al., 2012).
Differentially Localized LncRNAs
Lastly, we wanted to identify possible functional motifs in lncRNAs which are
differentially localized within the cell. For this test case we used published results from
which lncRNA transcript abundances were quantified from fractionated cellular
compartments, either from the nucleus or the cytoplasm (Derrien, et al., 2012). We
extracted the sequences for all lncRNAs quantified between the nuclear and cytoplasmic
fractions, using sequences enriched in the nucleus as our positive sequence set and the
cytoplasmic lncRNAs as the negative set. This data resulted in a set of 1749 lncRNA
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transcripts with a total sequence length of 2.42 megabases, of which 981 sequences are
enriched in the nucleus while 768 are enriched in the cytoplasm. Using the nuclear
transcripts as our positive set and the cytoplasmic transcripts as our negative set we ran the
GA on this large dataset to identify 14-mers associated with subcellular localization (Figure
4.2).
Notably, the best motif identified contains a core pentamer RNA motif previously
identified to dictate nuclear localization of lncRNAs (B. Zhang, et al., 2014). The pentamer
RNA sequence motif was found to be AGCCC with the restriction sites of (G or C) at -3
and (T or A) at -8, which the motif we identified contains all of, except the -8 restriction
site (B. Zhang, et al., 2014). Next, we calculated the total matches of the identified motif
in each sequence set, finding 3,133 instances of the motif in the nuclear set and only 1,871
in the negative set. Furthermore, the counts of this motif in each lncRNA shows a small
yet significant correlation with the nuclear/cytoplasm FPKM ratio (Pearson’s Correlation
Coefficient = 0.14, p-value = 4.31×10-9).
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Figure 4.2 Motif found in nuclear enriched lncRNAs. The output of the genetic algorithm
ran with the nuclear enriched lncRNA transcripts as the positive set and the cytoplasmic
lncRNAs as the negative set. The first plot shows the fitness per generation. The second
figure is the sequence logo of the best motif found.
4.4 Conclusion
Based on our preliminary observations we have shown that our genetic algorithm is
capable of identifying discriminative motifs in large sequence sets, such as sequence sets
containing thousands of lncRNA transcripts. We demonstrated that our algorithm can
achieve high accuracy in synthetic tests despite a high noise to signal ratio. In addition,
utilizing entire lncRNA transcripts derived from the transcript quantification of
fractionated cells we have identified a motif enriched in nuclear transcripts. Remarkably,
the motif identified recapitulates an experimentally identified lncRNA localization motif
identified in an independent study (B. Zhang, et al., 2014). The counts of this motif in the
lncRNA transcripts also shows a significant positive correlation with subcellular
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localization. This preliminary work shows that it is possible to computationally identify
functional motifs in previously uncharacterized lncRNAs.
Our method is capable of handling large input sequence sets as well as identifying
arbitrarily large motifs. In addition, to speed up the motif identification process over a
range of motif widths (w), solutions from the final population can be used as a seed
population for identifying motifs of size w+1. This procedure can be done iteratively and
will speed up the motif identification procedure because the initial population will already
contain informative seed motifs to be expanded upon. Furthermore, the genetic algorithm
framework could likely be improved upon through augmentation of the genetic operators.
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CHAPTER V - PREDICTION OF LNCRNA SUBCELLULAR
LOCALIZATION WITH DEEP LEARNING FROM SEQUENCE
FEATURES
Brian L. Gudenas and Liangjiang Wang,*
Department of Genetics and Biochemistry, Clemson University, Clemson, SC, USA
*Corresponding author: liangjw@clemson.edu
Abstract
Long noncoding RNAs are involved in biological processes throughout the cell including
the nucleus, chromatin and cytosol. However, most lncRNAs remain unannotated and
functional annotation of lncRNAs is difficult due to their low conservation and their tissue
and developmentally specific expression. LncRNA subcellular localization is highly
informative regarding its biological function, although it is difficult to discover because no
prediction methods currently exist. While protein subcellular localization prediction is a
well-established research field, lncRNA localization prediction is a novel research
problem. We developed DeepLncRNA, a deep learning algorithm which predicts lncRNA
subcellular localization directly from transcript sequences. We identified differentially
localized lncRNAs using 93 strand-specific RNA-seq samples, from multiple cell types,
which underwent fractionation to isolate the nucleus and cytosol prior to RNA-seq.
Sequence-based features were extracted from the lncRNAs to train the model, achieving
high prediction accuracy, demonstrating that primary sequence motifs are a major driving
force in the subcellular localization of lncRNAs. DeepLncRNA obtained an accuracy of
73.3%, sensitivity of 80.7%, specificity of 66.2% and area under the receiver operating
characteristic curve of 0.812.
5.1 Introduction
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The inner workings of the cell are orchestrated by complex interactions between
the products of DNA, both noncoding RNAs and proteins. This idea has superseded the
view that proteins and their corresponding messenger RNA (mRNA) are solely responsible
for cellular function. Noncoding RNAs are now known to be an integral functional
component of genetic regulation, and are involved in crucial roles such as the regulation of
gene expression. The most prevalent and one of the most functionally diverse classes of
noncoding RNAs are the long noncoding RNAs (lncRNAs).
LncRNAs are large RNA transcripts which do not encode proteins and are
estimated to outnumber protein-coding genes within the human genome (Iyer, et al., 2015).
However, lncRNAs are poorly conserved at the sequence level, which makes functional
annotation difficult. LncRNAs perform a diverse repertoire of essential molecular
functions, in many different subcellular locations (Geisler and Coller, 2013). However,
determining the functional role of lncRNAs experimentally is highly time-consuming and
laborious. Like proteins, lncRNA functionality is dependent on proper subcellular
localization. LncRNA transcripts can localize in many different places within the cell,
including the chromatin, nucleus, cytoplasm and exosomes (Heesch, et al., 2014; Morris,
2016). Knowing the localization patterns of lncRNAs allows the inference of their
biological functional. Therefore, the possibility to learn where any given lncRNA localizes
would provide valuable information regarding its biological function as well as the RNA
localization mechanism.
LncRNA subcellular localization is likely dependent on many factors, including
sequence and structural motifs which can facilitate binding to proteins involved in

74

localization (Goff and Rinn, 2015). Identification of structural motifs in lncRNAs is
currently problematic both experimentally and computationally due to the high-level of
complexity of intra-molecular organization that lncRNAs can exhibit (Yan, et al., 2016).
However, sequence motifs in lncRNAs associated with subcellular localization have been
identified such as the pentamer motif AGCCC which is highly associated with lncRNA
nuclear localization (B. Zhang, et al., 2014). Therefore, it is evident that motifs in the
lncRNA primary sequence are involved in lncRNA subcellular localization. While,
obtaining lncRNA structural data is difficult, lncRNA transcript sequences are readily
available.
Protein subcellular localization has been an active research area for decades and many
localization motifs have been identified. These localization motifs either reside in the
primary sequence, such as the N-terminal signal peptide associated with the secretory
pathway, or within the 3D protein structure, such as DNA-binding domains in nuclear
proteins. A well-known method for protein subcellular localization prediction is MultiLoc,
a support vector machine (SVM) which used sequence-derived features to achieve an
average accuracy of 75% (Höglund, et al., 2006). DeepLoc, a deep learning algorithm,
recently achieved an accuracy of 91% on the same data set used by MultiLoc (Almagro
Armenteros, et al., 2017). However, the proteins in this dataset have been found to be
highly homologous and therefore might provide an overly optimistic model evaluation.
Using a more comprehensive dataset of proteins which localize to ten different subcellular
locations, DeepLoc achieved an accuracy of 77%, while MultiLoc2, an upgraded version
of MultiLoc, only achieved an accuracy of 55% (Almagro Armenteros, et al., 2017).
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Sequence-based features thus appear to be highly informative for protein subcellular
localization and deep learning attains exceptional accuracy in comparison to other machine
learning algorithms. Despite the well-established knowledge regarding protein localization
prediction, we know relatively nothing about the prediction of lncRNA localization.
Our goal is to learn a model that predicts lncRNA subcellular localization directly from
lncRNA nucleotide sequences. We have chosen to utilize a deep neural network (DNN),
which have shown promise in many bioinformatics applications such as the annotation of
noncoding variants and identification of enhancers (Quang, et al., 2015; Kim, et al., 2016).
Deep learning methods, such as DNNs, avoid the need to manually craft informative
features and instead automatically learn high-level features through the iterative
aggregation of features in each layer of the network. Since nuclear retention motifs have
already been found in nucleus-localized lncRNAs, differences in sequence composition
between distinct nuclear and cytosolic lncRNAs are expected (B. Zhang, et al., 2014). In
this study, we performed used binary classification to learn how to discriminate between
differentially localized nuclear and cytosolic lncRNAs.

Our task is to predict the

subcellular localization of lncRNAs based on their transcript sequence, therefore we named
our algorithm DeepLncRNA, an acronym for “Deep Learning of Nuclear Classification of
long noncoding RNAs”. We trained our model on the sequences of differentially localized
lncRNAs, which are either enriched in the nucleus or the cytosol. DeepLncRNA scans the
lncRNA sequence, computing a range of k-mer frequencies and protein-binding motifs
which are then used to predict the lncRNA localization.
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Sequence-based features were extracted from lncRNA transcript sequences,
suggesting that our methodology could be easily applied to uncharacterized lncRNAs.
LncRNAs are lowly conserved between species, and a large fraction of human lncRNAs
are even primate-specific (Necsulea, et al., 2014; Washietl, et al., 2014). Therefore, our
model could be applicable to lncRNAs in closely related primates such as the chimpanzee
or bonobo. This study represents a first step in lncRNA subcellular localization prediction
which will be a valuable resource for the functional annotation of this large, diverse and
not yet fully understood class of noncoding genes.
5.2 Methods
Datasets
We analyzed paired-end strand-specific RNA-sequencing data from human cell lines
from the ENCODE project (Bernstein, et al., 2012). Samples underwent cellular
fractionation, to separate either the nucleus or cytosol, prior to RNA-seq. In total, we
acquired 93 RNA-seq profiles from 14 human immortalized cell lines, of which 45 were
from the cytosol and 48 from the nucleus. All cell lines were required to contain at least
two samples from each cellular fraction. Samples underwent different RNA library
protocols such as poly(A)+ (n = 62), total RNA (n = 8) or poly(A)- (n = 23). Using the total
RNA and poly(A)- library protocols in addition to the standard poly(A)+ samples allows a
complete transcriptomic analysis of lncRNAs, which are not all polyadenylated. All sample
metadata, as well as transcriptome alignment rates are displayed in (Additional file A-9).
Raw RNA-seq reads were mapped to the human transcriptome and quantified using
Kallisto (v0.43.1), (Bray, et al., 2016). In total, ~ 6 billion reads were aligned to the human
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transcriptome. Differential transcript expression analysis between the nuclear and cytosolic
fractions for each cell type was performed using Sleuth (R package, v0.29.0) which was
shown to be superior to other methods at identifying differentially expressed transcripts
(Pimentel, et al., 2016). If multiple RNA library protocols were used for a single cell type
then we added this as a covariate when testing for differential transcript expression.
Identification of Differentially Localized Human LncRNAs
We performed differential transcript expression to quantify the differences in
lncRNA transcript abundances between the nuclear and cytosolic cellular fractions for each
cell type. We aggregated the log2 fold-change values for each lncRNA across all cell-types
using a weighted average. Computing the nuclear to cytosolic log2 fold change allowed the
examination of the distribution of lncRNA subcellular localization for over 18000 lncRNA
transcripts (Figure 5.1). In agreement with previous studies, we found lncRNAs to be
predominantly enriched in the nucleus (Derrien, et al., 2012; Djebali, et al., 2012).
However, we do detect a large portion of lncRNAs (n = 4380) with transcript abundances
higher in the cytosol than the nucleus (Figure 5.1). Part of the nuclear skew of this
distribution is likely explained by the fact that all lncRNAs, regardless of destination, must
originate in the nucleus through the act of transcription. Furthermore, once transcribed the
export of lncRNAs from the nucleus to the cytoplasm must take some amount of time due
to the export mechanism, such as assembly of ribonucleoprotein complexes and
recruitment of exporters (Köhler and Hurt, 2007). Due to these two factors we expect the
median lncRNA nuclear to cytosol transcript ratio to be greater than zero and indeed the
median log2 fold-change was 1.6. Therefore, since our distribution is not centered at zero,
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like a standard differential expression test, we must adjust the commonly used symmetric
log2 fold-change threshold to classify differential expression. To account for the nuclear
skew of transcript ratios we selected new log2 fold-change thresholds, corresponding to the
first and fourth quartile, to signify differential localization (cytosolic < 0, nuclear > 2.8).
Applying these fold-change thresholds to our data resulted in a balanced dataset of 4380
cytosolic lncRNAs and 4298 nuclear lncRNAs. The dataset was then split into a training,
validation and testing set using a randomized 70/15/15 percent split.

Figure 5.1 Distribution of the lncRNA nuclear to cytosolic transcript ratios. A histogram
showing the log2 fold-change ratios for lncRNA transcripts (n = 18,068) detected across
all cell types. Colored bars indicate differentially localized lncRNAs which passed fold-
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change thresholds (Cytosolic < 0; Nuclear > 2.8) resulting in a training set of 4380
cytosolic lncRNAs and 4298 nuclear lncRNAs.

Extraction of Sequence Features from LncRNAs
To derive sequence-based features of uniform length from transcript sequences of
variable length we counted k-mers. Using the sequences of the differentially localized
lncRNAs we computed a k-mer frequency matrix, containing the frequency of all possible
oligonucleotides for k equal to two through five resulting in (42+43+44+45) = 1360 k-mer
features. In addition, the genomic loci of lncRNAs are known to be important regarding
their functionality which is why lncRNAs are classified based on their genomic context
such as, intergenic, antisense or sense lncRNAs (Ma, et al., 2013). Therefore, we added
additional features representing these major lncRNA subtypes based on the transcript
annotations from ENSEMBL. We also added the chromosomal location of the lncRNA to
further capture any effects of its genomic location. Lastly, the binding of RNA by proteins
represents a possible mechanism in which lncRNAs may be localized. Therefore, we added
features representing the presence of known RNA-binding motifs which were obtained
from the CISBP—RNA database (Ray, et al., 2013). Matches were counted using a slidingwindow approach, and a match was scored if the sub-sequence obtained a log-likelihood
position weight matrix (PWM) score greater than 80% of the maximal PWM score
(Andersen, et al., 2008). In total, we obtained 1582 sequence-based features which are the
inputs for DeepLncRNA (Figure 5.2).
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Figure 5.2 Overview of the DeepLncRNA algorithm
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Deep Neural Network Model
DeepLncRNA is a feed-forward multi-layer deep neural network. The architecture
used consists of one input layer, three hidden layers using the rectified linear unit activation
function and a softmax output layer. Hidden layer dropout was applied which randomly
masks half of the connections in each layer during training of the DNN which reduces the
propensity for overfitting. Input dropout was also applied which randomly masks some of
the hidden units in each layer to increase the generalizability of the model. Furthermore,
regularization was applied using the L1 and L2 weight penalties to the cost function. All
model parameter values were selected using a random search over all possible parameter
combinations seeking to minimize the misclassification rate on the validation set
(Additional File A-10). DeepLncRNA was trained with stochastic gradient descent using
the backpropagation algorithm which adjusts network weights by minimizing the error
between the response variable and the predicted output. DeepLncRNA was built using the
h2o R package (H2O.ai, 2017).
Evaluation Criteria
In this work, we develop a DeepLncRNA to identify lncRNAs to be enriched in the
nucleus (positive class) or cytosol (negative class). We use the common machine learning
evaluation metrics such as accuracy, sensitivity, specificity and Matthews correlation
coefficient respectively defined below.
TP = True Positive
TN = True Negative
FP = False Positive
FN = False Negative
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𝐴𝑐𝑐𝑢𝑟𝑎𝑐𝑦 =

𝑇𝑃+𝑇𝑁
𝑇𝑃+𝑇𝑁+𝐹𝑃+𝐹𝑁

𝑆𝑒𝑛𝑠𝑖𝑡𝑖𝑣𝑡𝑦 =

𝑇𝑃
𝑇𝑃 + 𝐹𝑁

𝑆𝑝𝑒𝑐𝑖𝑓𝑖𝑐𝑡𝑦 =

𝑇𝑁
𝑇𝑁 + 𝐹𝑃

𝑀𝐶𝐶 =

𝑇𝑃 × 𝑇𝑁 − 𝐹𝑃 × 𝐹𝑁
√(𝑇𝑃 + 𝐹𝑃)(𝑇𝑃 + 𝐹𝑁)(𝑇𝑁 + 𝐹𝑃)(𝑇𝑁 + 𝐹𝑁)

5.3 Results
To evaluate the performance of DeepLncRNA we compared it to other advanced
machine learning algorithms. We compared DeepLncRNA with a random forest (RF) and
support vector machine (SVM) (Figure 5.3). Based on all three measures, accuracy,
specificity and sensitivity DeepLncRNA achieved better performance. The ability to
abstract complex non-linear features does appear to enhance the performance of
DeepLncRNA compared with the other machine learning algorithms. Interestingly, the
specificity of every model is more than 5% lower than its sensitivity. Specificity, known
as the true negative rate, represents the ability to correctly identify cytosolic lncRNAs,
suggesting that it is more difficult to predict cytosolic localization than nuclear localization.
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Figure 5.3 Model selection based on performance metrics on the validation set. The
performance metrics of DeepLncRNA, random forest (RF) and radial support vector
machine (SVM) on the validation set.
Model parameters were selected based on the maximization of accuracy on the
validation set. Since DeepLncRNA has more parameters than either the random forest or
support vector machine it is possibly an over-optimistic evaluation of its accuracy.
Therefore, we generated ROC curves on the unseen test set for all three models (Figure
5.4). The ROC curve shows DeepLncRNA has the highest discriminatory power between
the nuclear and cytosolic lncRNAs. Furthermore, we compared DeepLncRNA to the other
machine learning models using a range of performance metrics and found DeepLncRNA
achieved better performance on every metric except specificity (Table 5.1). While
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DeepLncRNA obtained a specificity 4.5% lower than that of a random forest, its sensitivity
is 8.1% higher. Based on the more comprehensive metrics such as accuracy, AUC and
MCC, we conclude that DeepLncRNA is the optimal model for the prediction of lncRNA
subcellular localization.

Figure 5.4 ROC curve performance comparison on the test set.
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Table 5.1 Performance metrics on the test set.

Model

Accuracy

Sensitivity Specificity AUC MCC

RF

0.716

0.726

0.707

0.788

0.433

SVM

0.713

0.721

0.706

0.795

0.427

DeepLncRNA

0.733

0.807

0.662

0.812

0.473

To show that DeepLncRNA can be applied to lncRNAs in cell types other than the ones
used for training, we examined the role that cell type has on lncRNA subcellular
localization. Different cell types have distinct gene expression profiles which means
different abundances of the export machinery, such as exporter proteins, which could be
needed for specific lncRNAs to exit the nucleus. Therefore, we visualized the conservation
of lncRNA subcellular localization across all cell types used in this study (Figure 5.5).
Despite the vast differences in tissue types, lncRNA subcellular localization appears highly
conserved across cell type. Since the subcellular localization of a lncRNA is not dependent
on cell-type, our model is applicable to all human lncRNAs. However, for a small number
of lncRNAs there are changes in subcellular localization between certain cell types. This
suggests that it may be beneficial to add cell type specific features in the future for the
prediction of lncRNA subcellular localization.
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Figure 5.5 Heatmap of lncRNA nuclear to cytosolic transcript ratios across cell types. Each
bar is a lncRNA transcript colored according to its nuclear to cytosolic log2 fold-change
(L2FC) in the respective cell type, white bars indicate the lncRNA was not detected in that
cell type. Cell types were then clustered based on their lncRNA localization patterns.

To examine the subcellular localization properties of different subcategories of lncRNAs
we used DeepLncRNA to predict the subcellular localization of all annotated human
lncRNAs, excluding any lncRNAs in our training set. In total, we predicted the localization

87

of over 20,000 lncRNAs which we then grouped by gene biotype and evaluated based on
the proportion which localize to the nucleus (Figure 5.6). Intriguingly, we observed
drastically different proportions of nuclear localization between lncRNA biotypes. Most
notably, sense intronic lncRNAs, which reside in the intron of a protein-coding gene, are
almost entirely predicted to be enriched in the nucleus. In fact, sense overlapping lncRNAs
which can share exons with protein-coding genes are also predicted to be highly nuclear.
Thus, both types of sense lncRNAs appear to be highly nuclear which may suggest they
predominantly function in the cis-regulation of their embedded protein-coding gene.
Almost half of antisense lncRNAs are predicted to be enriched in the cytosol. This is
compatible with the fact that many antisense lncRNAs are known to increase the stability
of their cognate mRNA by protection from miRNA in the cytoplasm (Rashid, et al., 2016).
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Figure 5.6 Percent of annotated lncRNAs predicted to localize in the nucleus.
DeepLncRNA predictions of the localization of all annotated lncRNAs grouped by
lncRNA biotype. Each bar represents the total percent of lncRNAs in that biotype that are
predicted to be localized in the nucleus. The red vertical line represents the boundary
between a predominantly cytosolic enriched or nuclear enriched biotype.
Next, we compared the predictions of DeepLncRNA with experimental results
from RNA profiling studies of lncRNA subcellular localization. Several lncRNAs have
already had their subcellular localization studied through experimental approaches such as
fluorescent in situ hybridization of RNA (Cabili, et al., 2015). From the current literature
we curated a list of twenty-one lncRNAs with known subcellular localizations, including
three lncRNAs which were found to be dual-localized in both subcellular fractions
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(Additional file A-11). However, many of these differentially localized lncRNAs were
present in our dataset, therefore, we removed all of them from the training and validation
set and recreated DeepLncRNA using the exact same parameters originally used. We then
used the new version of DeepLncRNA to predict the subcellular localization of these
lncRNAs which have had their localization experimentally tested yet have never been seen
by our model (Figure 5.7). DeepLncRNA correctly predicted 8 out of 9 nuclear lncRNAs
and 6 out 9 cytoplasmic lncRNAs, based on greater than 50% probability for their
respective fraction. Despite not training on dual-localized lncRNAs, DeepLncRNA
predicted all three dual-localized lncRNAs are present in the cytoplasm which is correct.
The nuclear lncRNA BORG and the cytoplasmic linc-p21 included, are mouse lncRNAs
and DeepLncRNA correctly predicted the nuclear retention of BORG (Figure 5.7). These
results suggest DeepLncRNA learned generalizability sequence-based features which can
predict the lncRNA subcellular localization of novel lncRNAs.
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Figure 5.7 DeepLncRNA predictions on lncRNAs with known subcellular localizations.
A stacked bar plot showing the percent of lncRNA transcripts predicted to localize to a
specific subcellular fraction. LncRNA gene names colored by (red, black and blue)
represent nuclear, dual-localized and cytoplasmic lncRNAs, respectively, identified in
experimental studies (Additional File A-11).
5.4 Conclusion
In conclusion, we developed DeepLncRNA, a deep learning algorithm which
predicts lncRNA subcellular localization directly from lncRNA transcript sequences.
DeepLncRNA obtained better accuracy relative to other state-of-the-art machine learning
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algorithms and represents a major advancement in lncRNA subcellular localization
prediction. The high accuracy of DeepLncRNA indicates that lncRNA primary sequence
motifs play a large role in subcellular localization. We predicted the subcellular localization
of all annotated human lncRNAs, finding different biotypes possess distinct subcellular
localization properties. DeepLncRNA also correctly predicted the localization of more than
75% of a manually curated list of lncRNAs with experimentally validated localizations. In
the future, lncRNA subcellular localization prediction will enable the examination of the
role that disease-associated point mutations and copy-number variants have on lncRNA
function. Since DeepLncRNA is a novel model to predict lncRNA subcellular localization
and the number of lncRNAs is expanding we expect DeepLncRNA to play a pivotal role
in the functional annotation of lncRNAs.
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CHAPTER VI – CONCLUSIONS
In this study, we used genomic data mining methods for the functional annotation of human
lncRNAs. Methodologies were developed using either expression-based or sequence-based
approaches. For expression-based approaches, we selected two major neurodevelopmental
disorders as test cases to identify disease-associated lncRNAs. LncRNA expression was
evaluated using a gene coexpression network through the integration of RNA-seq datasets,
curated disease-associated gene lists and disease-specific mutational data. First, we curated
a list of high-confidence intellectual disability (ID) genes and built a genome-wide
coexpression network from RNA-seq data of the developing human brain. We detected a
gene module, associated with the immune response, which was specific to ID and the
lncRNAs in this module were highly expressed during the mid-to-late fetal period of
neurodevelopment. Furthermore, many of these ID-associated lncRNAs were validated
through integration of independent mutational data, suggesting that they harbor IDassociated CNVs.
To identify candidate autism spectrum disorder (ASD) associated lncRNAs, we
first identified lncRNAs differentially expressed in the ASD cortex, finding hundreds of
differentially expressed lncRNAs. To prioritize the lncRNA candidates, we used a brain
developmental coexpression network and identified which lncRNAs were highly coexpressed with ASD risk genes. This refined list of candidate ASD-associated lncRNAs
was then validated based on ASD mutational data, suggesting that these lncRNAs were
present in CNVs at a high frequency. Consequently, our final high-confidence ASDassociated lncRNAs were differentially expressed in the ASD brain, co-expressed with
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ASD risk genes in neurodevelopment and present in ASD-associated CNVs higher than
expected by chance. Coexpression network analysis is a useful methodology for the
functional annotation of lncRNAs because it allows the inference of lncRNA function,
based on a “guilt by association” heuristic, with genes of known function. Furthermore, we
have demonstrated that the approach can be augmented by the integration of different
datasets into the coexpression network such as disease gene lists, mutational data and
differential expression data. In the future, coexpression methodologies can be improved
upon from the integration of more data types such as methylation data, miRNA data, SNV
data and more disease-affected RNA-seq data.
Sequence-based approaches were also developed to discover new knowledge in
lncRNA transcript sequences. Due to the limitations of current motif finders, such as small
motif sizes and input sequence limits, we developed a genetic algorithm to find
discriminative functional motifs. This algorithm scans two sets of lncRNAs and finds a
position weight matrix which is enriched in one set yet not the other. Our preliminary
results show this algorithm can find large motifs, such as 15-mers, even when multiple
random positions are mutated in the test set. Furthermore, using a publicly available list of
differentially localized lncRNAs we found a motif that was experimentally associated with
nuclear localization of lncRNAs. Future work can likely improve the genetic algorithm
performance from the incorporation of more sophisticated motif representation schemes
such as hidden markov models which could capture more sequential information.
LncRNA’s biological function is heavily dependent on their subcellular
localization because certain functions are compartmentalized to specific cellular locations.
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We have constructed a deep learning model, DeepLncRNA, which predicts the nuclear or
cytosolic enrichment of a lncRNA directly from the transcript sequence. DeepLncRNA
was trained using more than six thousand differentially localized lncRNAs which were
identified from differential expression analysis of fractionated samples. DeepLncRNA
obtained high accuracy on the unseen test dataset and a curated high-confidence list of
known differentially localized lncRNAs. Furthermore, when DeepLncRNA was used to
predict the localization of all annotated lncRNAs, it found large differences in localization
trends between different lncRNA biotypes. While protein subcellular localization
prediction is a well-established field, lncRNA subcellular localization is a novel research
area which will greatly aid in the functional annotation of lncRNAs. In the future as
experimental data accumulates, more advanced sequence-based features can be added to
improve prediction accuracy, such as post-transcriptional modification motifs and
structure-associated motifs. Furthermore, RNA-seq data from fractionation techniques to
isolate the chromatin, nucleoplasm, ribosome and exosome fractions could be incorporated
into the training data to change the model into a multi-class predictor which should improve
discriminative power.
In the future, there are many paths toward more sophisticated functional
characterization of lncRNAs. For expression-based methods of lncRNA functional
annotation, the interaction of lncRNAs and protein-coding genes is only one component of
their regulatory function. Another known aspect of lncRNA functionality is their
interaction and regulation with small noncoding RNAs, such as miRNAs. However, most
RNA-seq protocols do not profile small RNAs like miRNAs due to either the RNA
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extraction technique used or a size selection screening based on sequence length.
Therefore, coexpression network analysis is missing an important piece of the puzzle for
the characterization of lncRNA function. The integration of miRNAs into coexpression
networks will allow the identification of miRNA-lncRNA interactions which could
function as regulatory control mechanisms for the gene expression of other genes. For
example, if a miRNA targets the mRNA of a disease gene, reducing its expression, and a
lncRNA is found to sequester that miRNA, then it could be said that this lncRNA is
indirectly regulating the disease gene. These type of complex functional relationships can
only be discovered if all RNA species are adequately profiled, small and large, prior to
coexpression network analysis.
Sequence-based methods for lncRNA functional annotation will also see great
improvements in the future, due to the accumulation of more data and the application of
sophisticated deep learning methodologies. The utilization of k-mers leave much to be
desired due to their omission of long-range sequential interactions and positional
information. Recurrent neural networks are being used to learn both short and long-range
sequential patterns in sequences of arbitrary length. These types of algorithms will be
superior in the functional characterization of lncRNAs due to the learning of both
sequential information, which motifs are present, as well as positional patterns, where are
the motifs located. The motifs identified by these models will provide great insight into the
biological function of lncRNAs by enabling the clustering of lncRNAs into functional
families based on short and long-range motif characteristics.
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As the number of lncRNAs appears to keep growing, data mining approaches will
become invaluable tools for the functional annotation of lncRNAs. Currently, expression
and sequence-based methods offer the best means of understanding lncRNA functionality.
Integrating both approaches will likely be the future of genomic data mining for lncRNA
functional annotation. Furthermore, as experimentally derived 3D structures of lncRNAs
accumulates structure-based approaches will likely fill in some of the missing pieces of
deciphering lncRNA functionality. Once we comprehend the functional transcriptome we
will began to unlock the secrets of disease and biological development.
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Appendix A –Additional Files
Additional File A-1 ID gene lists.
Additional File A-2 ID WGCNA results.
Additional File A-3 Modular ID gene enrichment.
Additional File A-4 Ranked ID lncRNAs.
Additional File A-5 Characteristics of genes differentially expressed in ASD.
Additional File A-6 R markdown document containing source code and exploratory
ASD data analysis.
Additional File A-7 ASD Weighted gene coexpression network analysis results.
Additional File A-8 Prioritized ASD-associated lncRNAs.
Additional File A-9 Subcellular localization RNA-seq sample metadata
Additional File A-10 DeepLncRNA parameter optimization
Additional File A-11 Manually curated lncRNAs with known localizations
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Appendix B – Supplementary Figures

Figure B-1 Tissue specificity of differentially expressed lncRNAs. The heatmap displays
lncRNAs median FPKM abundance for each human tissue type. LncRNAs were Z-score
normalized across tissue types, and then hierarchical clustering was performed on the
tissue types. The blue boxes adjacent to the hierarchical cluster tree denote if the tissue
type is derived from the brain.
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Figure B-2 Coexpression of developmental gene modules. The bar plot shows the
average biweight midcorrelation of all gene modules in the brain developmental network.
The red circle within each bar represents the average biweight midcorrelation of 10,000
randomly selected gene sets of equal size to the genes within the respective module.
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Figure B-3 Coexpression of ASD gene sets with differentially expressed lncRNAs. The
histograms display the summed biweight midcorrelation between ASD gene sets and
10,000 randomly selected gene sets of equal size to the differentially expressed lncRNAs.
The red vertical line represents the sum of the biweight midcorrelation between an ASD
gene set with the differentially expressed lncRNAs. P-values were calculated based on
the difference between the actual summed correlation (red line) and the permuted normal
distribution and adjusted for multiple comparisons (adjusted p-values < 0.001).
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